,Date,Title,Url
0,2018-01-02,더벨부광약품신약파이프라인임상개발박차,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201712290100047430002864
1,2018-01-03,더벨thebellnote부광약품의신약개발,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201801020100000430000020
2,2018-01-03,특징주부광약품강세신약개발속도안트로젠가치↑,http://www.edaily.co.kr/news/newspath.asp?newsid=01722006619074112
3,2018-01-03,부광약품안트로젠4거래일연속상승그래프,http://www.mdtoday.co.kr/mdtoday/index.html?no=307064
4,2018-01-03,fnRASSI부광약품735오르며거래량증가,http://www.fnnews.com/news/201801031109135719
5,2018-01-03,부광약품52주신고가갱신자회사약진,http://www.dailymedi.com/detail.php?number=826014&thread=22r05
6,2018-01-03,유부광약품전일대비1155상승일일회전율은444기록,http://www.sedaily.com/NewsView/1RUA97XI42
7,2018-01-03,유부광약품장중신고가돌파27000→28650▲1650,http://www.sedaily.com/NewsView/1RUAA1TTA1
8,2018-01-03,특징주부광약품신약개발속도에강세,http://www.newsway.co.kr/view.php?tp=1&ud=2018010315051937189
9,2018-01-04,안트로젠새해신고가행진에대주주부광약품강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=307162
10,2018-01-04,빅데이터MSI시장심리톱5POSCO부광약품OCI현대중공업대한항공,http://www.newsis.com/view/?id=NISX20180104_0000194051&cID=10401&pID=10400
11,2018-01-04,빅데이터MSI10시시장심리톱5POSCO부광약품OCI현대중공업대한항공,http://www.newsis.com/view/?id=NISX20180104_0000194221&cID=10401&pID=10400
12,2018-01-10,부광약품㈜부광메디카부문별사원모집1월14일채용마감,http://www.ekn.kr/news/article.html?no=336653
13,2018-01-12,fnRASSI부광약품302오르며거래량증가,http://www.fnnews.com/news/201801121028589466
14,2018-01-15,부광약품근육통타박상치료제타벡스겔90g대용량발매,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=214137
15,2018-01-15,부광약품타벡스겔용량늘린90g대용량발매,http://medipana.com/news/news_viewer.asp?NewsNum=214521&MainKind=A&NewsKind=5&vCount=12&vKind=1
16,2018-01-15,부광약품타박근육통치료제타벡스겔대용량발매,http://www.medicaltimes.com/News/1116268
17,2018-01-15,부광약품타벡스겔90g대용량발매,http://www.medical-tribune.co.kr/news/articleView.html?idxno=76752
18,2018-01-15,부광약품타벡스겔90g대용량발매,http://www.bosa.co.kr/news/articleView.html?idxno=2076338
19,2018-01-15,부광약품타벡스겔90g대용량출시,http://www.kpinews.co.kr/news/articleView.html?idxno=63849
20,2018-01-15,부광약품바르는타박상치료제타벡스겔90g대용량발매,http://www.mdtoday.co.kr/mdtoday/index.html?no=308250
21,2018-01-15,부광약품바르는근육통치료제타벡스겔대용량출시,http://www.rapportian.com/news/articleView.html?idxno=108455
22,2018-01-15,부광약품타박상근육통치료제타벡스겔90g대용량발매,http://www.viva100.com/main/view.php?key=20180115020021940
23,2018-01-26,부광약품당뇨병신약MLR1023글로벌임상순항,http://www.medicaltimes.com/News/1116506
24,2018-01-26,부광약품당뇨신약후기2상임상환자50등록,http://medipana.com/news/news_viewer.asp?NewsNum=215058&MainKind=A&NewsKind=5&vCount=12&vKind=1
25,2018-01-26,부광약품제2형당뇨신약글로벌후기2상임상순항,http://www.newsis.com/view/?id=NISX20180126_0000214212&cID=13001&pID=13000
26,2018-01-26,부광약품당뇨병신약글로벌후기임상2상환자50등록,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201801260469
27,2018-01-26,부광약품당뇨신약후기2상임상환자50등록,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018012615193635357
28,2018-01-26,부광약품제2형당뇨병신약임상2상순항,http://www.finomy.com/news/articleView.html?idxno=51335
29,2018-01-26,부광약품당뇨신약MLR1023후기2상임상환자50등록,http://www.mdtoday.co.kr/mdtoday/index.html?no=309631
30,2018-01-26,부광약품당뇨신약글로벌임상순항중,http://www.newstomato.com/ReadNews.aspx?no=802875
31,2018-01-26,부광약품제2형당뇨병신약글로벌후기임상2상순항,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=214552
32,2018-01-26,부광약품제2형당뇨병치료신약글로벌임상2상올해완료기대,http://biz.chosun.com/site/data/html_dir/2018/01/26/2018012602116.html
33,2018-01-26,부광약품당뇨병신약임상시험환자등록50예상보다빨라,http://www.edaily.co.kr/news/newspath.asp?newsid=03358726619081656
34,2018-01-26,ET투자뉴스안트로젠지분변동부광약품주외5명316p감소2379보유,http://www.etnews.com/20180126000464
35,2018-01-26,부광약품당뇨병치료신약개발임상2상순항,http://www.rapportian.com/news/articleView.html?idxno=108682
36,2018-01-30,더벨부광약품오너일가안트로젠지분대거매각,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201801290100056750003493
37,2018-01-30,개장전특징주부광약품003000,http://www.newstomato.com/ReadNews.aspx?no=803439
38,2018-01-30,유부광약품전일대비717상승일일회전율은244기록,http://www.sedaily.com/NewsView/1RUMNBWPQA
39,2018-01-31,매일장보는남녀부광약품003000,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003092848
40,2018-01-31,부광약품이상운동증치료제JM010용도및조성물특허청등록,http://www.fnnews.com/news/201801310930088192
41,2018-01-31,부광약품파킨슨병운동장애LID치료제특허등록,http://medipana.com/news/news_viewer.asp?NewsNum=215230&MainKind=A&NewsKind=5&vCount=12&vKind=1
42,2018-01-31,부광약품이상운동증치료제JM010특허등록,http://www.asiae.co.kr/news/view.htm?idxno=2018013109413012055
43,2018-01-31,부광약품파킨슨병부작용치료제특허등록,http://www.edaily.co.kr/news/newspath.asp?newsid=01990966619083296
44,2018-01-31,부광약품파킨슨병운동장애LID치료제JM010특허등록,http://www.mdtoday.co.kr/mdtoday/index.html?no=310052
45,2018-01-31,부광약품파킨슨병운동장애치료제등록,http://www.medical-tribune.co.kr/news/articleView.html?idxno=77107
46,2018-01-31,부광약품파킨슨병운동장애LID치료제JM010특허등록,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201801310081
47,2018-01-31,부광약품파킨슨병운동장애LID치료제JM010특허등록,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=214686
48,2018-01-31,부광약품파킨슨병운동장애치료물질특허등록,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180131065000017&did=1195m
49,2018-01-31,부광약품개발의약품특허등록완료,http://www.kpinews.co.kr/news/articleView.html?idxno=65233
50,2018-01-31,부광약품파킨슨병운동장애LID치료제특허,http://www.medicaltimes.com/News/1116584
51,2018-01-31,부광약품파킨슨병운동장애LID치료제JM010특허등록,http://www.newsis.com/view/?id=NISX20180131_0000218114&cID=13001&pID=13000
52,2018-01-31,제약바이오의료기기업계이모저모부광약품당뇨병신약글로벌임상2상진행,http://news.heraldcorp.com/view.php?ud=20180131000549
53,2018-01-31,부광약품파킨슨병운동장애LID치료제국내특허획득,http://www.ebn.co.kr/news/view/927997
54,2018-01-31,부광약품2월11일일까지신입사원모집,http://www.ekn.kr/news/article.html?no=340947
55,2018-01-31,부광약품파킨슨병치료제특허등록,http://www.dailymedi.com/detail.php?number=827050&thread=22r05
56,2018-01-31,부광약품파킨슨병운동장애치료제국내용도조성물특허등록,http://biz.chosun.com/site/data/html_dir/2018/01/31/2018013102462.html
57,2018-01-31,부광약품파킨슨병운동장애LID치료제JM010국제특허등록,http://www.viva100.com/main/view.php?key=20180131020022060
58,2018-02-01,부광약품전일대비약5하락한26350원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201802010343
59,2018-02-01,안트로젠부광약품총수일가지분매도회사경영과무관,http://news.hankyung.com/article/201802013696f
60,2018-02-02,부광약품전일대비약4하락한25200원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201802020491
61,2018-02-06,부광약품전일대비약4하락한23450원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201802060646
62,2018-02-12,단독부광약품먹는위암치료제임상3상조기완료가능성,http://biz.chosun.com/site/data/html_dir/2018/02/12/2018021201156.html
63,2018-02-12,유부광약품전일대비795상승일일회전율은099기록,http://www.sedaily.com/NewsView/1RVOBG2F31
64,2018-02-12,부광약품전일대비약4상승한24900원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201802120348
65,2018-02-12,부광약품먹는위암치료제상용화가능성,http://www.greened.kr/news/articleView.html?idxno=51410
66,2018-02-13,부광약품의코스메슈티컬브랜드피엘라토2018미베베이비엑스포참가,http://www.dailysecu.com/?mod=news&act=articleView&idxno=29944
67,2018-02-13,오늘의종목부광약품신약파이프라인창출의리더,http://www.sedaily.com/NewsView/1RVORQ5N7H
68,2018-02-27,부광약품오너2세김상훈대표3월주총서재선임,http://www.dailypharm.com/News/237169
69,2018-03-06,부광약품덱시드동남아4개국진출,http://www.newsis.com/view/?id=NISX20180306_0000244224&cID=13001&pID=13000
70,2018-03-06,부광약품덱시드동남아수출본격화,http://www.medical-tribune.co.kr/news/articleView.html?idxno=77742
71,2018-03-06,부광약품자체개발개량신약덱시드정동남아수출본격화,http://www.sportsseoul.com/news/read/608856
72,2018-03-06,부광약품개량신약덱시드동남아수출본격화,http://medipana.com/news/news_viewer.asp?NewsNum=216716&MainKind=A&NewsKind=5&vCount=12&vKind=1
73,2018-03-06,부광약품당뇨병성신경병증치료제덱시드동남아진출,http://www.edaily.co.kr/news/newspath.asp?newsid=03306246619140696
74,2018-03-06,부광약품당뇨병성신경병증치료제덱시드정동남아수출본격화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=215692
75,2018-03-06,부광약품동남아에당뇨병성신경병증개량신약수출,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803060434
76,2018-03-06,부광약품덱시드정동남아진출가시화,http://www.finomy.com/news/articleView.html?idxno=52318
77,2018-03-06,부광약품당뇨병성신경병증덱시드정필리핀베트남등동남아시장본격진출,http://www.fnnews.com/news/201803061552382543
78,2018-03-06,부광약품당뇨병성신경병증치료제덱시드정동남아진출,http://www.ebn.co.kr/news/view/932468
79,2018-03-06,부광약품개량신약덱시드로동남아땅밟는다,http://www.ajunews.com/view/20180306161826561
80,2018-03-06,부광약품개량신약덱시드정동남아수출본격화,http://view.asiae.co.kr/news/view.htm?idxno=2018030616303410123
81,2018-03-06,부광약품자체개발개량신약덱시드동남아수출본격화,http://news.kmib.co.kr/article/view.asp?arcid=0012179592&code=61171911&cp=nv
82,2018-03-06,부광약품개량신약덱시드동남아4개국수출,http://www.rapportian.com/news/articleView.html?idxno=109308
83,2018-03-06,부광약품덱시드동남아4개국수출본격화,http://www.medigatenews.com/news/2332490546
84,2018-03-06,부광약품자체개발개량신약덱시드동남아수출본격화,http://biz.chosun.com/site/data/html_dir/2018/03/06/2018030602186.html
85,2018-03-07,부광약품당뇨병신경병증신약덱시드동남아진출,http://www.bosa.co.kr/news/articleView.html?idxno=2079164
86,2018-03-07,부광약품개량신약덱시드동남아수출본격화,http://www.medicaltimes.com/News/1117229
87,2018-03-09,부광약품매출1507억87증가영업익순이익감소,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=215822
88,2018-03-13,부광약품1214일네덜란드바이오유럽스프링참석,http://www.fnnews.com/news/201803131623523414
89,2018-03-13,부광약품바이오유럽서당뇨파킨슨병신약비즈니스미팅진행,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=215931
90,2018-03-13,부광약품바이오유럽에서신약관련비즈니스미팅진행,http://www.medigatenews.com/news/2222020067
91,2018-03-13,부광약품바이오유럽에서신약비즈니스미팅진행,http://www.dt.co.kr/contents.html?article_no=2018031302109976029011&ref=naver
92,2018-03-13,부광약품바이오유럽서신약관련비즈니스미팅진행,http://www.newsis.com/view/?id=NISX20180313_0000251057&cID=13001&pID=13000
93,2018-03-13,부광약품바이오유럽에서신약관련비즈니스미팅진행,http://www.newspim.com/news/view/20180313000270
94,2018-03-13,부광약품바이오유럽서신약비즈니스미팅진행,http://medipana.com/news/news_viewer.asp?NewsNum=217068&MainKind=A&NewsKind=5&vCount=12&vKind=1
95,2018-03-13,부광약품바이오유럽서당뇨파킨슨병신약비즈니스미팅진행,http://www.etoday.co.kr/news/section/newsview.php?idxno=1603260
96,2018-03-13,부광약품바이오유럽서신약관련비즈니스미팅진행,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018031317511092081
97,2018-03-13,부광약품바이오유럽서기술이전모색,http://www.edaily.co.kr/news/newspath.asp?newsid=03663766619142992
98,2018-03-14,부광약품바이오유럽참석개발신약관련미팅40여건진행,http://www.newstomato.com/ReadNews.aspx?no=811577
99,2018-03-14,부광약품바이오유럽콘퍼런스서신약기술수출논의,http://biz.chosun.com/site/data/html_dir/2018/03/14/2018031401172.html
100,2018-03-14,부광약품5거래일연속상승전일대비3상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803140289
101,2018-03-14,바이오유럽참석해당뇨파킨슨병신약관련미팅진행한부광약품,http://www.insight.co.kr/news/144947
102,2018-03-15,부광약품1214일바이오유럽회의서신약개발상담진행,http://news.kmib.co.kr/article/view.asp?arcid=0012202360&code=61171911&cp=nv
103,2018-03-15,생생코스피부광약품3대주주김기환주총결의안건반대,http://news.heraldcorp.com/view.php?ud=20180315000756
104,2018-03-15,부광약품5거래일연속상승전일대비2상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803150444
105,2018-03-15,부광약품3대주주가주총안건반대운동,http://news.mt.co.kr/mtview.php?no=2018031516134922982
106,2018-03-15,기업분석부광약품성공적바이오벤처투자에도웃지못하는이유,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018031515595276947
107,2018-03-15,부광약품3대주주와갈등주총안건반대나서,http://www.mdtoday.co.kr/mdtoday/index.html?no=315082
108,2018-03-15,부광약품3대주주김기환씨주총결의안에브레이크,http://www.dailypharm.com/News/237708
109,2018-03-15,부광약품3대주주주총안건반대운동16일주총서오너家와충돌불가피,http://www.weeklytoday.com/news/articleView.html?idxno=64575
110,2018-03-16,부광약품주주와경영진갈등3대주주폐쇄경영위한정관개정반대”,http://www.kukinews.com/news/article.html?no=532022
111,2018-03-16,3대주주와갈등부광약품주총무사통과분쟁일단봉합,http://www.newspim.com/news/view/20180316000058
112,2018-03-16,부광약품유희원단독대표이사체계로변경,http://news.mt.co.kr/mtview.php?no=2018031613064090456
113,2018-03-16,부광약품유희원단독대표체제로,http://news.hankyung.com/article/2018031647236
114,2018-03-16,부광약품유희원단독대표이사체계로변경,http://www.etoday.co.kr/news/section/newsview.php?idxno=1604386
115,2018-03-16,부광약품유희원단독대표이사체계로변경,http://www.cstimes.com/?mod=news&act=articleView&idxno=270669
116,2018-03-16,ET투자뉴스부광약품지분변동김기환외3명02p감소654보유,http://www.etnews.com/20180316000142
117,2018-03-16,부광약품유희원단독대표이사체계로변경,http://www.sedaily.com/NewsView/1RX04HR4K3
118,2018-03-16,부광약품유희원단독대표체제로변경,http://www.newspim.com/news/view/20180316000134
119,2018-03-16,부광약품유희원단독대표이사체제로변경,http://www.newsis.com/view/?id=NISX20180316_0000254222&cID=10401&pID=10400
120,2018-03-16,ET투자뉴스부광약품지분변동정창수011p증가1211보유,http://www.etnews.com/20180316000149
121,2018-03-16,부광약품유희원단독대표체제로,http://view.asiae.co.kr/news/view.htm?idxno=2018031613484153916
122,2018-03-16,공시부광약품유희원단독대표체제로변경,http://www.ceoscoredaily.com/news/article.html?no=39036
123,2018-03-16,부광약품유희원단독대표이사체제로변경,http://www.econonews.co.kr/news/articleView.html?idxno=21261
124,2018-03-16,부광약품유희원단독대표이사체제로변경,http://www.mdtoday.co.kr/mdtoday/index.html?no=315194
125,2018-03-16,공시부광약품유희원단독대표이사체제로변경,http://www.newsway.co.kr/view.php?tp=1&ud=2018031615245121868
126,2018-03-16,주총부광약품유희원단독대표오너2세김상훈은사내이사,http://news1.kr/articles/?3262711
127,2018-03-16,부광약품다시전문경영인체제로전환유희원단독대표체제,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018031615562026619
128,2018-03-16,부광약품유희원대표이사단독체제전환,http://www.dailypharm.com/News/237744
129,2018-03-16,ET투자뉴스부광약품지분변동김동연외8명016p증가2645보유,http://www.etnews.com/20180316000305
130,2018-03-16,부광약품다시전문경영인체제로,http://biz.chosun.com/site/data/html_dir/2018/03/16/2018031602143.html
131,2018-03-19,부광약품주총원안대로유희원단독대표체제,http://www.sisaweek.com/news/articleView.html?idxno=104855
132,2018-03-19,부광약품오너2세→전문CEO유희원단독체제,http://www.dailymedi.com/detail.php?number=828577&thread=22r05
133,2018-03-19,부광약품유희원사장단독대표전문경영인체제재돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=216135
134,2018-03-19,부광약품7건안건압도적표차로원안대로통과,http://medipana.com/news/news_viewer.asp?NewsNum=217341&MainKind=A&NewsKind=5&vCount=12&vKind=1
135,2018-03-19,부광약품최근3년간영업외수익325억발생,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=216136
136,2018-03-19,부광약품국세청특별세무조사탈세비자금조성혐의,http://www.newsfc.co.kr/news/articleView.html?idxno=31686
137,2018-03-19,부광약품제58기정기주주총회개최,http://www.medigatenews.com/news/4232790070
138,2018-03-19,부광약품5년만에전문경영인단독체제회귀,http://www.ajunews.com/view/20180319175028005
139,2018-03-19,부광약품유희원단독대표체제로전환,http://www.insight.co.kr/news/145743
140,2018-03-19,국세청부광약품특별세무조사제약업계긴장,http://www.tfnews.co.kr/news/article.html?no=44914
141,2018-03-20,부광약품정기주총안건모두의결전문경영인체제돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=315427
142,2018-03-20,부광약품58회주주총회7안건원안대로가결,http://www.kpanews.co.kr/article/show.asp?idx=192243&table=article&category=D
143,2018-03-20,부광약품이다시전문경영인체제로전환한까닭은,http://www.rapportian.com/news/articleView.html?idxno=109532
144,2018-03-20,부광약품유희원단독대표전문경영인체제돌입,http://www.monews.co.kr/news/articleView.html?idxno=112392
145,2018-03-20,부광약품세무조사서울국세청지난15일부터,http://www.sisajournal-e.com/biz/article/181633
146,2018-03-21,부광약품IR부서신설국내외IR활동대폭강화,http://medipana.com/news/news_viewer.asp?NewsNum=217474&MainKind=A&NewsKind=5&vCount=12&vKind=1
147,2018-03-21,부광약품국내외IR활동강화,http://www.dt.co.kr/contents.html?article_no=2018032102109976029011&ref=naver
148,2018-03-21,부광약품기업홍보부서신설및전문가영입IR강화,http://news.hankyung.com/article/201803213117f
149,2018-03-21,부광약품IR부서신설전문가영입국내외IR대폭강화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=216232
150,2018-03-22,부광약품국내외IR활동대폭강화,http://www.bosa.co.kr/news/articleView.html?idxno=2080102
151,2018-03-22,유희원부광약품대표분기마다기관투자가만난다,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803210559
152,2018-03-22,부광약품국내외IR활동대폭강화대표직속IR팀신설,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018032208440516563
153,2018-03-22,부광약품국내외IR활동강화,http://news.heraldcorp.com/view.php?ud=20180322000070
154,2018-03-22,부광약품미국서투자설명회연다,http://www.ebn.co.kr/news/view/934594
155,2018-03-22,부광약품국내외IR활동대폭강화한다,http://www.sportsseoul.com/news/read/614385
156,2018-03-22,부광약품투자자에게기업설명강화하겠다,http://www.medical-tribune.co.kr/news/articleView.html?idxno=78059
157,2018-03-22,부광약품대표직속IR팀신설국내외소통강화,http://www.dailypharm.com/News/237933
158,2018-03-22,부광약품국내외IR활동대폭강화,http://www.kpanews.co.kr/article/show.asp?idx=192330&table=article&category=D
159,2018-03-22,부광약품IR팀신설해외기업홍보활동강화,http://www.rapportian.com/news/articleView.html?idxno=109587
160,2018-03-22,부광약품전일대비약3상승한26200원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803220304
161,2018-03-23,부광약품국내외IR활동강화,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1053902
162,2018-03-27,부광약품47조당뇨병치료제韓美임상2상순항”,http://view.asiae.co.kr/news/view.htm?idxno=2018032714464018925
163,2018-03-30,부광약품당뇨병치료제韓美임상2상순로조운진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=316791
164,2018-04-03,제약사들RD비율소폭감소‥부광약품첫20대진입,http://medipana.com/news/news_viewer.asp?NewsNum=218108&MainKind=A&NewsKind=5&vCount=12&vKind=1
165,2018-04-04,fnRASSI부광약품411오르며거래량증가,http://www.fnnews.com/news/201804040946024354
166,2018-04-04,부광약품전일대비약7상승한27250원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804040233
167,2018-04-04,유부광약품전일대비705상승일일회전율은180기록,http://www.sedaily.com/NewsView/1RY4J00VA3
168,2018-04-04,AIVS인간수익률빅매치신영목1위부광약품신규편입,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804040268
169,2018-04-04,부광약품5거래일연속상승전일대비7상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804040293
170,2018-04-05,부광약품㈜각부문신입및경력모집부문별마감일정상이,http://www.ekn.kr/news/article.html?no=354045
171,2018-04-09,부광약품정신분열증치료제루라시돈3상임상투약개시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=216916
172,2018-04-09,부광약품정신분열증치료제임상3상투약시작,http://www.newsis.com/view/?id=NISX20180409_0000276345&cID=13001&pID=13000
173,2018-04-09,유부광약품전일대비728상승일일회전율은186기록,http://www.sedaily.com/NewsView/1RY6U0978Z
174,2018-04-09,유부광약품장중신고가돌파28700→28800▲100,http://www.sedaily.com/NewsView/1RY6UPGOZL
175,2018-04-09,fnRASSI부광약품52주신고가728↑,http://www.fnnews.com/news/201804091355293105
176,2018-04-09,부광약품조현병약루라시돈3상임상시험투약개시,http://www.sisajournal-e.com/biz/article/182487
177,2018-04-09,부광약품정신분열증치료제루라시돈임상3상개시,http://biz.chosun.com/site/data/html_dir/2018/04/09/2018040901661.html
178,2018-04-09,부광약품정신분열증치료제3상임상투약시작,http://www.sedaily.com/NewsView/1RY6U0H8WX
179,2018-04-09,부광약품정신분열증치료제루라시돈3상임상시험투약개시,http://news.hankyung.com/article/201804099596f
180,2018-04-09,부광약품조현병치료제루라시돈3상투약개시,http://medipana.com/news/news_viewer.asp?NewsNum=218426&MainKind=A&NewsKind=5&vCount=12&vKind=1
181,2018-04-09,부광약품정신분열증약3상투약개시,http://www.newstomato.com/ReadNews.aspx?no=816997
182,2018-04-09,부광약품52주신고가경신전일대비9상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804090341&t=NN
183,2018-04-09,부광약품전일대비약9상승한29250원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804090343&t=NN
184,2018-04-09,부광약품정신분열증치료제루라시돈3상임상시험돌입,http://www.fnnews.com/news/201804091517596430
185,2018-04-09,부광약품정신분열치료제루라시돈임상3상개시,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804090354&t=NN
186,2018-04-09,부광약품정신분열증치료제루라시돈3상임상투약개시,http://www.newspim.com/news/view/20180409000204
187,2018-04-09,부광약품조현병치료제임상3상투약개시,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018040915372044655
188,2018-04-09,부광약품정신분열증약루라시돈3상투약시작,http://www.rapportian.com/news/articleView.html?idxno=109909
189,2018-04-09,부광약품조현병치료제루라시돈임상3상개시,http://www.dailymedi.com/detail.php?number=829357&thread=22r05
190,2018-04-09,부광약품루라시돈3상임상시험시작,http://www.fnnews.com/news/201804091658220315
191,2018-04-09,부광약품루라시돈임상3상투약개시,http://www.monews.co.kr/news/articleView.html?idxno=113271
192,2018-04-09,부광약품정신분열치료제루라시돈임상3상본격화,http://www.finomy.com/news/articleView.html?idxno=53410
193,2018-04-09,부광약품루라시돈3상임상시험투약개시,http://www.medigatenews.com/news/2440035510
194,2018-04-09,부광약품수백억기대주조현병약루라시돈3상개시,http://www.ajunews.com/view/20180409173256781
195,2018-04-09,부광약품정신분열증제루라시돈3상투약개시,http://www.dailypharm.com/News/238636
196,2018-04-09,부광약품정신분열증치료제루라시돈3상개시,http://www.medicaltimes.com/News/1117960
197,2018-04-10,부광약품정신분열병치료제루사시돈3상순항,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1054585
198,2018-04-10,유부광약품장중신고가돌파29500→30350▲850,http://www.sedaily.com/NewsView/1RY79RS4EC
199,2018-04-10,fnRASSI부광약품52주신고가119↑,http://www.fnnews.com/news/201804101131046066
200,2018-04-11,부광약품정신분열증치료제루라시돈3상임상시험개시,http://www.kpanews.co.kr/article/show.asp?idx=192899&table=article&category=D
201,2018-04-11,유부광약품장중신고가돌파30600→30950▲350,http://www.sedaily.com/NewsView/1RY7QW5XXI
202,2018-04-11,특징주부광약품4일째강세조현병치료제3상투약,http://www.newspim.com/news/view/20180411000065
203,2018-04-11,유부광약품전일대비725상승일일회전율은110기록,http://www.sedaily.com/NewsView/1RY7PTNUTT
204,2018-04-11,부광약품정신분열증치료제루라시돈임상3상투약시작,http://www.mdtoday.co.kr/mdtoday/index.html?no=317961
205,2018-04-11,부광약품52주신고가경신전일대비7상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804110145&t=NN
206,2018-04-11,부광약품전일대비약8상승한31900원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804110146&t=NN
207,2018-04-11,fnRASSI부광약품52주신고가759↑,http://www.fnnews.com/news/201804111011428568
208,2018-04-11,제약바이오의료기기이모저모부광약품정신분열증치료제루라시돈3상임상,http://news.heraldcorp.com/view.php?ud=20180411000586
209,2018-04-12,부광약품오픈이노베이션RD강자,http://www.newstomato.com/ReadNews.aspx?no=817862
210,2018-04-16,유부광약품전일대비765상승일일회전율은124기록,http://www.sedaily.com/NewsView/1RYA1IX73W
211,2018-04-16,부광약품전일대비약9상승한31350원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804160271&t=NN
212,2018-04-16,fnRASSI부광약품003000852상승,http://www.fnnews.com/news/201804161303007443
213,2018-04-16,부광약품10급등전일보다3000원상승한31750원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804160344&t=NN
214,2018-04-18,오마이스탁배현철대표의상담종목부광약품한진칼外,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018041814285163910
215,2018-04-19,ET투자뉴스부광약품지분변동김동연외8명2645보유,http://www.etnews.com/20180419000042
216,2018-04-19,부광약품김동연회장아들과딸에게400만주증여,http://medipana.com/news/news_viewer.asp?NewsNum=218930&MainKind=A&NewsKind=5&vCount=12&vKind=1
217,2018-04-19,부광약품김동연회장400만주증여,http://www.kpanews.co.kr/article/show.asp?idx=193150&table=article&category=D
218,2018-04-19,부광약품김동연회장700억원규모400만주세자녀에증여,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=217291
219,2018-04-19,부광약품김동연회장1170억상당400만주증여,http://www.dailymedi.com/detail.php?number=829740&thread=22r05
220,2018-04-19,김동연부광약품회장김상훈이사등자녀에게400만주증여,http://www.newspim.com/news/view/20180419000102
221,2018-04-19,부광약품김동연회장자녀들에시가400만주증여,http://www.medigatenews.com/news/2634579457
222,2018-04-19,자녀에게1000억원대주식깜짝증여한김동연부광약품회장왜,http://www.ebn.co.kr/news/view/938400
223,2018-04-19,DailyPharma부광약품김동연회장자녀에게400만주증여,http://www.econovill.com/news/articleView.html?idxno=336168
224,2018-04-19,부광약품김동연회장700억원규모주식자녀증여,http://www.getnews.co.kr/news/articleView.html?idxno=63713
225,2018-04-19,부광약품김동연회장장남등세자녀에400만주증여,http://view.asiae.co.kr/news/view.htm?idxno=2018041910521063285
226,2018-04-19,부광약품최대주주김동연회장400만주자식에게증여,http://www.fnnews.com/news/201804191058205788
227,2018-04-19,김동연부광약품회장2세에400만주증여700억원납세예상,http://www.sisajournal-e.com/biz/article/182912
228,2018-04-19,부광약품2세승계작업돌입1170억원주식증여,http://www.medicaltimes.com/News/1118182
229,2018-04-19,김동연부광약품회장자녀에주식400만주증여,http://www.kpinews.co.kr/news/articleView.html?idxno=71838
230,2018-04-19,김동연부광약품회장자녀들에게400만주증여,http://news1.kr/articles/?3294516
231,2018-04-19,김동연부광약품회장400만주증여,http://www.dt.co.kr/contents.html?article_no=2018041902109976029005&ref=naver
232,2018-04-19,김동연부광약품회장장남두딸에400만주증여,http://www.rapportian.com/news/articleView.html?idxno=110098
233,2018-04-19,김동연부광약품회장자녀에게400만주증여,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804190158&t=NN
234,2018-04-19,부광약품김동연회장아들딸등에400만주증여,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1055033
235,2018-04-19,부광약품김동연회장400만주공개증여,http://www.bosa.co.kr/news/articleView.html?idxno=2081920
236,2018-04-19,부광약품김동연회장자녀에게400만주증여,http://www.sportsseoul.com/news/read/625361
237,2018-04-19,부광약품경영승계주식양도추진수백억세금납부투명화,http://www.ajunews.com/view/20180419133722346
238,2018-04-19,부광약품김동연회장자녀들에게400만주증여,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018041914532269049
239,2018-04-19,부광약품김동연회장자녀에게천억원대주식증여,http://www.mdtoday.co.kr/mdtoday/index.html?no=318847
240,2018-04-19,부광약품김동연회장400만주증여,http://news.heraldcorp.com/view.php?ud=20180419000835
241,2018-04-19,부광약품김동연회장소유주식400만주아들딸에게증여,http://www.fnnews.com/news/201804191737260013
242,2018-04-19,부광약품김동연회장소유주식400만주아들딸에게증여,http://www.fnnews.com/news/201804191742428531
243,2018-04-19,마켓인사이트부광약품승계작업본격화김동연회장자녀들에게주식증여,http://news.hankyung.com/article/201804195810u
244,2018-04-19,김동연부광약품회장400만주세자녀에증여시가1170억원,http://www.viva100.com/main/view.php?key=20180419010007348
245,2018-04-20,부광약품김동연회장세무조사속2세들에400만주증여,http://www.medisobizanews.com/news/articleView.html?idxno=52742
246,2018-04-23,부광약품전일대비약4하락한26100원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804230193&t=NN
247,2018-04-23,부광약품증여결정신약자신감때문,http://news.heraldcorp.com/view.php?ud=20180423000743
248,2018-04-24,부광약품경영승계에옛동업자집안과갈등,http://news.mt.co.kr/mtview.php?no=2018042311365087116
249,2018-04-25,부광약품덱시드정제네릭42품목생물학적동등성인정,http://www.yakup.com/news/index.html?mode=view&cat=11&nid=217489
250,2018-04-26,부광약품동업자집안과경영권분쟁불거지나,http://www.newsworker.co.kr/news/articleView.html?idxno=17473
251,2018-04-26,부광약품10년만에변비치료제아락실TV광고재개,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018042617562022692
252,2018-04-26,부광약품10년만에아락실TV광고재개,http://medipana.com/news/news_viewer.asp?NewsNum=219299&MainKind=A&NewsKind=5&vCount=12&vKind=1
253,2018-04-26,부광약품변비치료제아락실광고재개,http://www.kpinews.co.kr/news/articleView.html?idxno=72443
254,2018-04-26,부광약품아락실10년만에TV광고재개OTC사업부도약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=217577
255,2018-04-27,부광약품아락실10년만에TV광고,http://www.medical-tribune.co.kr/news/articleView.html?idxno=78841
256,2018-04-27,부광약품10년만에아락실TV광고재개,http://www.sisajournal-e.com/biz/article/183332
257,2018-04-27,부광약품생약성분변비약아락실10년만에TV광고재개,http://www.viva100.com/main/view.php?key=20180426010009941
258,2018-04-27,아락실시린메드부광약품헬스케어사업재정비추진,http://www.ajunews.com/view/20180427160934510
259,2018-04-27,부광약품아락실10년만에광고재개로브랜드UP,http://www.getnews.co.kr/news/articleView.html?idxno=65750
260,2018-04-29,부광약품아락실TV광고재개,http://www.dailymedi.com/detail.php?number=830057&thread=22r05
261,2018-05-01,건강한픽템식물성식이성분으로안심”부광약품아락실,http://www.etoday.co.kr/news/section/newsview.php?idxno=1618879
262,2018-05-02,부광약품BK에스키모알티지오메가3출시,http://www.dailypharm.com/News/239409
263,2018-05-02,부광약품BK에스키모알티지오메가3출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=217691
264,2018-05-02,부광약품BK에스키모알티지오메가3출시,http://www.dailymedi.com/detail.php?number=830162&thread=22r05
265,2018-05-02,유부광약품전일대비712상승일일회전율은082기록,http://www.sedaily.com/NewsView/1RZDK9ZIS3
266,2018-05-02,부광약품전일대비약6상승한27600원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805020212&t=NN
267,2018-05-02,부광약품BK에스키모알티지오메가3출시,http://www.getnews.co.kr/news/articleView.html?idxno=66706
268,2018-05-02,제약바이오의료기기이모저모부광약품10년만에아락실TV광고재개,http://news.heraldcorp.com/view.php?ud=20180502000572
269,2018-05-03,부광약품알래스카산고순도BK에스키모알티지오메가3출시,http://www.viva100.com/main/view.php?key=20180502010000983
270,2018-05-03,부광약품5월7일월까지약국영업부문신입사원모집,http://www.ekn.kr/news/article.html?no=359967
271,2018-05-04,제약산업부광약품아락실10년만에TV광고재개外,http://www.kukinews.com/news/article.html?no=545920
272,2018-05-10,부광약품아세트아미노펜서방정325mg출시,http://medipana.com/news/news_viewer.asp?NewsNum=219853&MainKind=A&NewsKind=5&vCount=12&vKind=1
273,2018-05-10,부광약품타세놀ER서방정,http://www.medical-tribune.co.kr/news/articleView.html?idxno=79104
274,2018-05-10,부광약품아세트아미노펜서방정인타세놀이알서방정325mg출시,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018051015001434748
275,2018-05-10,부광약품아세트아미노펜서방정325mg출시,http://www.metroseoul.co.kr/news/newsview?newscd=2018051000176
276,2018-05-10,부광약품용량낮춘아세트아미노펜내놔과다복용위험줄여,http://www.newsis.com/view/?id=NISX20180510_0000305072&cID=13001&pID=13000
277,2018-05-10,부광약품타세놀이알서방정325mg출시,http://www.whosaeng.com/sub_read.html?uid=101284§ion=sc5
278,2018-05-10,부광약품저용량타세놀이알서방정325mg출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=218017
279,2018-05-10,부광약품해열진통소염제타세놀이알서방정출시,http://www.rapportian.com/news/articleView.html?idxno=110457
280,2018-05-10,부광약품용량낮춘아세트아미노펜서방정출시과다복용위험방지,http://www.etoday.co.kr/news/section/newsview.php?idxno=1621785
281,2018-05-10,부광약품저용량지속형타이레놀복제약출시,http://news.hankyung.com/article/201805100094f
282,2018-05-10,부광약품아세트아미노펜서방정인타세놀이알서방정325mg출시,http://www.getnews.co.kr/news/articleView.html?idxno=68538
283,2018-05-10,부광약품저용량해열진통소염제출시과다복용방지,http://view.asiae.co.kr/news/view.htm?idxno=2018051018170936496
284,2018-05-11,부광약품타세놀이알서방정325mg출시,http://www.dailymedi.com/detail.php?number=830437&thread=22r05
285,2018-05-11,부광약품아세트아미노펜서방정인타세놀이알서방정325mg출시,http://news.kmib.co.kr/article/view.asp?arcid=0012346694&code=61171911&cp=nv
286,2018-05-14,부광약품해열진통제타세놀이알서방정325㎎출시,http://www.viva100.com/main/view.php?key=20180510010003803
287,2018-05-15,부광약품오르카파마지분투자회수로330억원수익예상,http://www.fnnews.com/news/201805150953326847
288,2018-05-15,릴리의MA로60억이익본부광약품최대330억,http://medipana.com/news/news_viewer.asp?NewsNum=220035&MainKind=A&NewsKind=5&vCount=12&vKind=1
289,2018-05-15,부광약품오르카파마투자수익330억원예상,http://www.newspim.com/news/view/20180515000122
290,2018-05-15,아파야챙길래일동제약한미약품부광약품外,http://www.g-enews.com/ko-kr/news/article/news_all/201805151029594310e6a49afa8d_1/article.html
291,2018-05-15,부광약품오르카파마지분회수로330억수익예상,http://www.newsis.com/view/?id=NISX20180515_0000308728&cID=13001&pID=13000
292,2018-05-15,부광약품오르카파마투자수익발생,http://www.kpanews.co.kr/article/show.asp?idx=193830&table=article&category=D
293,2018-05-15,릴리항암제개발회사인수하자부광약품웃었다,http://www.biospectator.com/view/news_view.php?varAtcId=5473
294,2018-05-15,부광약품캐나다오르카파마투자로330억수익,http://www.sisajournal-e.com/biz/article/183964
295,2018-05-15,부광약품해외바이오벤처투자로최대330억수익발생,http://www.etoday.co.kr/news/section/newsview.php?idxno=1623133
296,2018-05-15,부광약품오르카파마투자총330억원수익발생,http://www.getnews.co.kr/news/articleView.html?idxno=69478
297,2018-05-15,릴리MA로부광약품돈방석,http://www.monews.co.kr/news/articleView.html?idxno=114691
298,2018-05-15,부광약품오르카파마투자수익발생총330억수익예상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=218155
299,2018-05-15,부광약품바이오벤처투자로330억투자수익예상,http://view.asiae.co.kr/news/view.htm?idxno=2018051514445756950
300,2018-05-15,부광약품캐나다오르카파마투자로330억원수익발생예상,http://news.hankyung.com/article/201805156078f
301,2018-05-15,부광약품바이오벤처오르카파마투자로330억수익예상,http://www.businesskorea.co.kr/news/articleView.html?idxno=22283
302,2018-05-15,부광약품㈜ETCOTC마케팅PM경력사원모집5월20일채용마감,http://www.ekn.kr/news/article.html?no=362179
303,2018-05-15,실적속보부광약품1Q영업이익16억전년비43↓,http://www.itooza.com/common/iview.php?no=2018051517140160803
304,2018-05-16,부광약품오르카파마투자수익금330억,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1055896
305,2018-05-16,부광약품캐나다오르카파마투자최대330억원수익,http://www.viva100.com/main/view.php?key=20180515010005305
306,2018-05-16,단독부광약품美투자사주력신약FDA에판매허가신청임박,http://www.nspna.com/news/?mode=view&newsid=284313
307,2018-05-18,부광약품맞춤형건기식영양제우건비3종출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=218297
308,2018-05-18,부광약품소비자맞춤형건기식우건비3종출시,http://medipana.com/news/news_viewer.asp?NewsNum=220231&MainKind=A&NewsKind=5&vCount=12&vKind=1
309,2018-05-18,부광약품우리가족건강비밀우건비3종출시,http://www.bosa.co.kr/news/articleView.html?idxno=2083529
310,2018-05-18,부광약품건기식우건비3종출시,http://www.kpinews.co.kr/news/articleView.html?idxno=74068
311,2018-05-18,부광약품우리가족건강비밀우건비3종출시,http://medipana.com/news/news_viewer.asp?NewsNum=220247&MainKind=A&NewsKind=5&vCount=12&vKind=1
312,2018-05-18,부광약품항암제라인업확장시동간암전립선암개발진행,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=218338
313,2018-05-18,부광약품항암제라인업본격확장나서,http://www.fnnews.com/news/201805181537546420
314,2018-05-18,부광약품간암전립선암등항암제개발본격진행,http://www.newspim.com/news/view/20180518000232
315,2018-05-18,부광약품간암전립선암치료제개발항암제라인업확장,http://www.newsis.com/view/?id=NISX20180518_0000312834&cID=13001&pID=13000
316,2018-05-18,부광약품항암제라인업확장본격화‥조직도강화,http://medipana.com/news/news_viewer.asp?NewsNum=220268&MainKind=A&NewsKind=5&vCount=12&vKind=1
317,2018-05-18,부광약품항암제라인업확장전립선암개량신약내년상반기임상시험,http://www.etoday.co.kr/news/section/newsview.php?idxno=1624582
318,2018-05-18,부광약품건강기능식품우건비출시,http://www.rapportian.com/news/articleView.html?idxno=110616
319,2018-05-18,부광약품항암제라인업확장본격시동,http://www.whosaeng.com/sub_read.html?uid=101499§ion=sc5
320,2018-05-18,부광약품간∙전립선항암제라인업확장본격시동,http://www.getnews.co.kr/news/articleView.html?idxno=70260
321,2018-05-18,부광약품항암제포트폴리오강화간암전립선암신약개발박차,http://www.rapportian.com/news/articleView.html?idxno=110622
322,2018-05-18,부광약품가족맞춤형영양제우건비3종출시,http://www.viva100.com/main/view.php?key=20180518010006486
323,2018-05-18,부광약품항암제파이프라인확대영업조직강화,http://www.viva100.com/main/view.php?key=20180518010006484
324,2018-05-21,부광약품우리가족건강비밀우건비3종출시,http://www.kpanews.co.kr/article/show.asp?idx=193982&table=article&category=D
325,2018-05-21,부광약품항암제라인업확장본격시동,http://www.kpanews.co.kr/article/show.asp?idx=193991&table=article&category=D
326,2018-05-21,부광약품항암제라인업확장가동,http://www.monews.co.kr/news/articleView.html?idxno=114918
327,2018-05-21,부광약품항암제라인업확장본격시동간암등치료제개발진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=321577
328,2018-05-25,더벨부광약품새먹거리항암제시장본격공략,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201805240100038890002387
329,2018-05-28,fnRASSI부광약품268오르며거래량증가,http://www.fnnews.com/news/201805281206035011
330,2018-05-30,OCI부광약품주식151만주취득지분율31,http://www.edaily.co.kr/news/newspath.asp?newsid=03876966619214168
331,2018-05-30,OCI부광약품151만주취득결정,http://news.mt.co.kr/mtview.php?no=2018053016114452125
332,2018-05-30,공시OCI부광약품주식151만주취득,http://www.newsway.co.kr/view.php?tp=1&ud=2018053016151811109
333,2018-05-30,공시OCI부광약품151만786주취득,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018053016165002892&LinkID=632&objId=A2018053016165002892&portalCode=naver
334,2018-05-30,OCI부광약품151만주취득결정,http://www.sedaily.com/NewsView/1RZQFCFIZW
335,2018-05-30,OCI부광약품주식151만주취득,http://www.asiatoday.co.kr/view.php?key=20180530010015274
336,2018-05-30,OCI부광약품제약바이오사업제휴,http://www.newsway.co.kr/view.php?tp=1&ud=2018053016191035119
337,2018-05-30,OCI부광약품과손잡고제약바이오사업진출,http://www.fnnews.com/news/201805301621110631
338,2018-05-30,OCI부광약품지분309인수제약바이오산업진출,http://news.mt.co.kr/mtview.php?no=2018053016091422249
339,2018-05-30,부광약품자사주151만786주처분결정,http://news.heraldcorp.com/view.php?ud=20180530000784
340,2018-05-30,부광약품429억원규모자기주식처분,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180530132100008&did=1195m
341,2018-05-30,부광약품OCI제약∙바이오사업제휴합작법인설립,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=218671
342,2018-05-30,OCI부광약품과합작투자사업의결제약바이오산업진출,http://www.asiatoday.co.kr/view.php?key=20180530010015287
343,2018-05-30,화학∙에너지기업과손잡은부광약품‥신성장기대,http://medipana.com/news/news_viewer.asp?NewsNum=220739&MainKind=A&NewsKind=5&vCount=12&vKind=1
344,2018-05-30,OCI부광약품합작제약바이오시장진출,http://news1.kr/articles/?3331487
345,2018-05-30,OCI부광약품제약바이오합작사설립신약개발벤처투자,http://biz.chosun.com/site/data/html_dir/2018/05/30/2018053002409.html
346,2018-05-30,부광약품OCI맞손신약개발JV설립,http://www.sedaily.com/NewsView/1RZQG101U9
347,2018-05-30,부광약품OCI와바이오벤처설립OCI부광약품151만주매입,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805300481&t=NN
348,2018-05-30,부광약품OCI와합작투자법인설립매년100억원공동투자,http://www.newsis.com/view/?id=NISX20180530_0000322867&cID=13001&pID=13000
349,2018-05-30,OCI부광약품과제약바이오사업제휴,http://www.dailian.co.kr/news/view/716490/?sc=naver
350,2018-05-30,OCI부광약품과제약바이오JV설립연100억원이상투자,http://www.dt.co.kr/contents.html?article_no=2018053002109932781012&ref=naver
351,2018-05-30,공시부광약품429억원규모자기주식처분,http://www.newsway.co.kr/view.php?tp=1&ud=2018053016431248048
352,2018-05-30,OCI부광약품과7월중합작법인설립제약바이오진출,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180530134800003&did=1195m
353,2018-05-30,OCI제약바이오사업진출부광약품과맞손,http://moneys.mt.co.kr/news/mwView.php?no=2018053016408056681
354,2018-05-30,OCI부광약품주식151만주취득제약바이오사업제휴,http://www.newsis.com/view/?id=NISX20180530_0000322880&cID=10401&pID=10400
355,2018-05-30,부광약품태양광전문기업OCI와제약바이오사업제휴,http://www.rapportian.com/news/articleView.html?idxno=110815
356,2018-05-30,OCI부광약품과손잡고제약바이오사업진출,http://www.greendaily.co.kr/news/article.html?id=20180530130029
357,2018-05-30,OCI부광약품제약바이오사업제휴매년100억이상투자,http://www.ceoscoredaily.com/news/article.html?no=41892
358,2018-05-30,OCI부광약품지분3취득제약바이오산업진출,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805300508&t=NN
359,2018-05-30,부광약품OCI조인트벤처설립바이오역량강화,http://www.dailypharm.com/News/240335
360,2018-05-30,OCI제약바이오시장진출부광약품과전략적제휴,http://www.m-i.kr/news/articleView.html?idxno=419939
361,2018-05-30,OCI제약바이오사업출사표부광약품합작,http://www.ebn.co.kr/news/view/943363
362,2018-05-30,부광약품OCI제약바이오사업제휴,http://www.bosa.co.kr/news/articleView.html?idxno=2084178
363,2018-05-30,OCI부광약품제약바이오사업맞손,http://amenews.kr/news/view.php?idx=36644
364,2018-05-30,부광약품OCI신약개발조인트벤처공동설립,http://news1.kr/articles/?3331496
365,2018-05-30,OCI부광약품제약바이오사업제휴조인트벤처사설립매년100억이상공동투자,http://www.econonews.co.kr/news/articleView.html?idxno=26049
366,2018-05-30,OCI부광약품제약바이오JV설립신약개발등에매년100억원이상투자,http://www.businesskorea.co.kr/news/articleView.html?idxno=22695
367,2018-05-30,OCI부광약품과손잡고제약바이오사업진출,http://view.asiae.co.kr/news/view.htm?idxno=2018053017231012034
368,2018-05-30,OCI부광약품과손잡고제약바이오신사업진출,http://www.viva100.com/main/view.php?key=20180530010010512
369,2018-05-30,마켓인사이트OCI부광약품김상훈사장백기사되나,http://news.hankyung.com/article/201805301274u
370,2018-05-30,OCI부광약품손잡고제약바이오시장진출,http://news.mk.co.kr/newsRead.php?year=2018&no=343683
371,2018-05-30,부광약품OCI제약바이오합작사설립매년100억이상투자,http://news.hankyung.com/article/201805300245f
372,2018-05-30,OCI부광약품손잡고제약바이오진출,http://www.fnnews.com/news/201805301725307994
373,2018-05-30,부광약품OCI제약바이오사업제휴합작사설립,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018053017215340986
374,2018-05-30,OCI부광약품손잡고제약바이오사업나선다,http://www.etoday.co.kr/news/section/newsview.php?idxno=1627803
375,2018-05-30,부광약품OCI신약개발공동투자제약바이오사업제휴,http://www.getnews.co.kr/news/articleView.html?idxno=72690
376,2018-05-30,OCI부광약품과손잡고제약바이오산업진출키로,http://news.mk.co.kr/newsRead.php?year=2018&no=343747
377,2018-05-30,부광약품OCI제약바이오사업제휴,http://www.whosaeng.com/sub_read.html?uid=101728§ion=sc5
378,2018-05-30,OCI부광약품과손잡고제약바이오사업진출,http://www.newstomato.com/ReadNews.aspx?no=827195
379,2018-05-30,매년100억투입부광약품OCI와신약개발맞손,http://www.edaily.co.kr/news/newspath.asp?newsid=04431286619214168
380,2018-05-30,부광약품OCI제약∙바이오사업에50대50합작투자,http://www.fnnews.com/news/201805301811367165
381,2018-05-30,부광약품OCI와손잡고신약개발나선다,http://www.newspim.com/news/view/20180530000451
382,2018-05-30,부광약품OCI와합작투자사업제휴의결,http://www.kpinews.co.kr/news/articleView.html?idxno=74968
383,2018-05-30,부광약품OCI제약∙바이오사업제휴,http://www.kpanews.co.kr/article/show.asp?idx=194258&table=article&category=D
384,2018-05-30,OCI부광약품제약∙바이오사업제휴,http://www.lawissue.co.kr/view.php?ud=201805301854171230204ead0791_12
385,2018-05-30,OCI부광약품손잡고제약바이오진출,http://www.g-enews.com/ko-kr/news/article/news_all/20180530185954338496aa5dcdf1_1/article.html
386,2018-05-30,OCI부광약품주식151만786주취득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1627880
387,2018-05-30,OCI와부광약품제약바이오합작회사설립하고매년100억투자,http://www.businesspost.co.kr/BP?command=article_view&num=84098
388,2018-05-30,OCI부광약품과바이오사업제휴,http://www.todayenergy.kr/news/articleView.html?idxno=203554
389,2018-05-31,비바100김동연부광약품회장증여세700억당당히낸다사업성장자신감,http://www.viva100.com/main/view.php?key=20180530010010185
390,2018-05-31,더벨맞손부광약품OCI동갑내기오너교감부각,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201805300100052290003260
391,2018-05-31,부광약품OCI사와신약개발합작법인설립추진,http://www.medisobizanews.com/news/articleView.html?idxno=53472
392,2018-05-31,한경로보뉴스부광약품5이상상승20181Q매출액352억40영업이익16억435,http://news.hankyung.com/article/201805313163L
393,2018-05-31,특징주부광약품OCI신약개발협업소식에동반상승,http://www.edaily.co.kr/news/newspath.asp?newsid=02210726619214496
394,2018-05-31,특징주OCI부광약품제약바이오사업제휴에강세,http://www.newsis.com/view/?id=NISX20180531_0000323457&cID=10401&pID=10400
395,2018-05-31,화학과제약이만났다OCI부광약품합작법인설립,http://www.enewstoday.co.kr/news/articleView.html?idxno=1195570
396,2018-05-31,부광약품OCI제약바이오합작법인설립50대50투자,http://www.viva100.com/main/view.php?key=20180530010010572
397,2018-05-31,OCI428억부광약품지분취득,http://www.mdtoday.co.kr/mdtoday/index.html?no=322591
398,2018-05-31,OCI부광약품맞손제약바이오합작법인설립,http://www.wolyo.co.kr/news/articleView.html?idxno=61879
399,2018-05-31,부광약품은왜자사주전량을OCI에넘겼나,http://www.dailypharm.com/News/240358
400,2018-05-31,OCI부광약품과손잡고제약바이오진출,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1056486
401,2018-05-31,이데일리NOCI부광약품과손잡고신약개발나서합작사설립外,http://www.edaily.co.kr/news/newspath.asp?newsid=03109446619214496
402,2018-05-31,화학기업OCI부광약품과제약산업진출,http://www.munhwa.com/news/view.html?no=2018053101071639176001
403,2018-05-31,OCI부광약품자사주151만주매입5050합작투자JV결정,http://www.kukinews.com/news/article.html?no=553533
404,2018-05-31,화학에너지OCI부광약품과제휴제약바이오진출,http://www.dailymedi.com/detail.php?number=831096&thread=22r05
405,2018-05-31,OCI세무조사속부광약품과손잡고조인트벤처투혼,http://www.intn.co.kr/news/articleView.html?idxno=2000501
406,2018-05-31,금맥찾는부광약품화학에너지기업과합작투자,http://www.monews.co.kr/news/articleView.html?idxno=115343
407,2018-05-31,OCI부광약품제약바이오부문합작투자사업의결,http://www.mdtoday.co.kr/mdtoday/index.html?no=322644
408,2018-05-31,손잡은OCI부광약품희비엇갈려,http://www.mdtoday.co.kr/mdtoday/index.html?no=322662
409,2018-05-31,OCI부광약품제약바이오사업제휴,http://daily.hankooki.com/lpage/economy/201805/dh20180531190728138080.htm
410,2018-06-01,화학에너지OCI부광약품과제휴제약바이오진출신호탄,http://www.nbntv.co.kr/news/articleView.html?idxno=104321
411,2018-06-02,부광약품신약전략임상진전주목골든브릿지,http://www.choicenews.co.kr/news/articleView.html?idxno=41896
412,2018-06-04,부광약품2분기영업실적1분기수준전망골든브릿지증권,http://news.mt.co.kr/mtview.php?no=2018060408233386408
413,2018-06-04,부광약품OCI와JV설립으로사업시너지↑,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018060408515600465&LinkID=632&objId=A2018060408515600465&portalCode=naver
414,2018-06-08,오픈이노베이션속도내는부광약품신약개발로중심이동,http://news.hankyung.com/article/201806081570f
415,2018-06-11,더벨부광약품의성장전략,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201806080100010550000659
416,2018-06-11,부광약품티트리성분여성청결제멜라진겔출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=219014
417,2018-06-11,부광약품티트리오일성분여성청결제멜라진겔출시,http://www.getnews.co.kr/news/articleView.html?idxno=75510
418,2018-06-11,부광약품티트리오일성분여성청결제멜라진겔출시,http://www.medisobizanews.com/news/articleView.html?idxno=53645
419,2018-06-11,부광약품티트리오일성분유일한여성청결제출시,http://medipana.com/news/news_viewer.asp?NewsNum=221190&MainKind=A&NewsKind=5&vCount=12&vKind=1
420,2018-06-11,DailyPharma부광약품無색소여성청결제멜라진겔출시”,http://www.econovill.com/news/articleView.html?idxno=339570
421,2018-06-11,부광약품여성청결제멜라진겔출시,http://www.whosaeng.com/sub_read.html?uid=102012§ion=sc5
422,2018-06-11,부광약품여성청결제멜라진출시,http://www.edaily.co.kr/news/newspath.asp?newsid=03755606619240736
423,2018-06-11,부광약품여성청결제멜라진출시,http://www.rapportian.com/news/articleView.html?idxno=111003
424,2018-06-11,부광약품안전한티트리오일여성청결제멜라진출시,http://news.mk.co.kr/newsRead.php?year=2018&no=368719
425,2018-06-11,부광약품티트리오일성분여성청결제멜라진겔출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1630824
426,2018-06-11,부광약품티트리오일여성청결제멜라진출시,http://www.g-enews.com/ko-kr/news/article/news_all/201806111817484091e6a49afa8d_1/article.html
427,2018-06-12,부광약품티트리성분여성청결제멜라진겔,http://www.kpanews.co.kr/article/show.asp?idx=194523&table=article&category=D
428,2018-06-12,부광약품티트리성분여성청결제멜라진출시,http://www.dailypharm.com/News/240734
429,2018-06-12,부광약품티트리성분여성청결제멜라진겔출시,http://www.viva100.com/main/view.php?key=20180612010003456
430,2018-06-19,부광약품전일대비약3하락한26100원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806190320&t=NN
431,2018-06-19,부광약품발에직접뿌리는무좀약더모메디큐액출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=219282
432,2018-06-19,부광약품분무식무좀치료제더모메디큐출시,http://medipana.com/news/news_viewer.asp?NewsNum=221547&MainKind=A&NewsKind=5&vCount=12&vKind=1
433,2018-06-19,부광약품뿌리는무좀치료제더모메디큐액출시,http://www.medisobizanews.com/news/articleView.html?idxno=53762
434,2018-06-19,부광약품뿌리는무좀치료제더모메디큐액출시,http://www.rapportian.com/news/articleView.html?idxno=111154
435,2018-06-19,부광약품5성분복합뿌리는무좀치료제더모메디큐액출시,http://www.viva100.com/main/view.php?key=20180619010006109
436,2018-06-20,부광약품뿌리는무좀치료제더모메디큐액출시,http://www.dailypharm.com/News/240941
437,2018-06-20,부광약품스프레이용무좀치료제더모메디큐액출시,http://www.getnews.co.kr/news/articleView.html?idxno=77642
438,2018-06-22,부광약품생두유효성분추출다이어트건기식론칭,http://medipana.com/news/news_viewer.asp?NewsNum=221708&MainKind=A&NewsKind=5&vCount=12&vKind=1
439,2018-06-22,부광약품다이어트건강기능식품그린커피빈슬림출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=219421
440,2018-06-22,부광약품다이어트건기식그린커피빈슬림출시,http://www.medisobizanews.com/news/articleView.html?idxno=53824
441,2018-06-22,부광약품다이어트건강기능식품그린커피빈슬림출시,http://www.ajunews.com/view/20180622104950718
442,2018-06-22,부광약품다이어트건기식그린커피빈슬림출시,http://biz.chosun.com/site/data/html_dir/2018/06/22/2018062201274.html
443,2018-06-22,부광약품다이어트건기식그린커피빈슬림출시,http://news.mk.co.kr/newsRead.php?year=2018&no=394467
444,2018-06-22,부광약품다이어트건기식그린커피빈슬림출시,http://www.dailypharm.com/News/241053
445,2018-06-22,부광약품다이어트건강기능식품그린커피빈슬림출시,http://www.getnews.co.kr/news/articleView.html?idxno=78285
446,2018-06-22,부광약품그린커피빈슬림발매,http://www.kpinews.co.kr/news/articleView.html?idxno=76598
447,2018-06-22,부광약품다이어트건기식그린커피빈슬림출시,http://www.viva100.com/main/view.php?key=20180622010007391
448,2018-06-24,부광약품다이어트건식그린커피빈슬림출시,http://www.rapportian.com/news/articleView.html?idxno=111235
449,2018-06-25,부광약품안전보건경영시스템새국제표준제약사최초인증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=219503
450,2018-06-25,부광약품안전보건경영시스템ISO45001인증,http://www.dailypharm.com/News/241108
451,2018-06-25,부광약품안전보건경영시스템새국제표준인증,http://www.newsis.com/view/?id=NISX20180625_0000345503&cID=13001&pID=13000
452,2018-06-25,부광약품안전보건경영시스템국제표준ISO45001인증,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018062514262350981
453,2018-06-25,부광약품안전보건경영시스템국제표준인증,http://view.asiae.co.kr/news/view.htm?idxno=2018062514535876940
454,2018-06-25,부광약품국제안전보건경영시스템ISO45001인증,http://www.medisobizanews.com/news/articleView.html?idxno=53853
455,2018-06-25,부광약품안전보건경영시스템국제표준ISO45001획득,http://www.ajunews.com/view/20180625145316882
456,2018-06-25,부광약품제약최초안전보건경영국제표준인증,http://medipana.com/news/news_viewer.asp?NewsNum=221811&MainKind=A&NewsKind=5&vCount=12&vKind=1
457,2018-06-25,부광약품안전보건국제표준ISO45001인증획득,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806250476&t=NN
458,2018-06-25,부광약품안전보건경영국제표준인증획득,http://www.finomy.com/news/articleView.html?idxno=55682
459,2018-06-25,부광약품안전보건경영시스템새국제표준인증획득,http://www.getnews.co.kr/news/articleView.html?idxno=78794
460,2018-06-25,부광약품안전보건경영시스템ISO45001인증,http://www.dailymedi.com/detail.php?number=831866&thread=22r05
461,2018-06-25,부광약품안전보건경영시스템새국제표준ISO45001인증,http://www.viva100.com/main/view.php?key=20180625010008103
462,2018-06-26,부광약품안전보건국제표준ISO45001인증,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1057316
463,2018-06-26,부광약품ISO45001인증,http://www.monews.co.kr/news/articleView.html?idxno=116173
464,2018-06-26,부광약품안전보건경영시스템ISO45001인증,http://www.bokuennews.com/news/article.html?no=161543
465,2018-06-28,부광약품다이어트건강기능식품그린커피빈슬림출시,http://www.kpanews.co.kr/article/show.asp?idx=194922&table=article&category=D
466,2018-06-28,부광약품안전보건경영시스템새국제표준ISO45001인증,http://www.kpanews.co.kr/article/show.asp?idx=194932&table=article&category=D
467,2018-06-29,유희원부광약품대표OCI와동행빅파마계약가능성↑,http://www.dailypharm.com/Users/News/NewsView.html?ID=241233&REFERER=NP
468,2018-07-02,부광약품시린메드에프∙검케어∙클로브에센스제품출시,http://www.getnews.co.kr/news/articleView.html?idxno=80200
469,2018-07-02,부광약품시린메드에프TV광고윤여정이서진편재개,http://www.medisobizanews.com/news/articleView.html?idxno=53972
470,2018-07-02,부광약품시린메드에프TV광고캠페인진행,http://www.rapportian.com/news/articleView.html?idxno=111393
471,2018-07-02,부광약품시린메드에프TV광고윤여정이서진편재개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=219767
472,2018-07-02,부광약품시린메드에프TV광고온에어,http://www.dailypharm.com/News/241351
473,2018-07-02,부광약품시린메드에프TV광고윤여정이서진편재개,http://www.kpanews.co.kr/article/show.asp?idx=195047&table=article&category=D
474,2018-07-03,연속기획재계리더회장님이사는집부광약품김상훈,http://www.ilyosisa.co.kr/news/articleView.html?idxno=147533
475,2018-07-03,부광약품전일대비약5하락한21900원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807030441&t=NN
476,2018-07-04,ET투자뉴스부광약품지분변동국민연금공단외1명103p증가713보유,http://www.etnews.com/20180704000080
477,2018-07-04,부광약품임상2상후기당뇨병신약이달내환자모집종료예정,http://www.fnnews.com/news/201807041422250747
478,2018-07-04,부광약품당뇨신약MLR10233조매출에한걸음,http://medipana.com/news/news_viewer.asp?NewsNum=222281&MainKind=A&NewsKind=5&vCount=12&vKind=1
479,2018-07-04,부광약품이달당뇨병신약임상2b상환자모집완료예상,http://news.hankyung.com/article/201807044961f
480,2018-07-04,부광약품당뇨신약이달내후기2상환자모집종료,http://www.medisobizanews.com/news/articleView.html?idxno=54040
481,2018-07-04,부광약품당뇨병신약MLR10232상후기환자모집완료,http://www.newsis.com/view/?id=NISX20180704_0000354497&cID=13001&pID=13000
482,2018-07-04,부광약품당뇨병신약2상후기환자모집이달종료예상매출3조원이상기대,http://www.newspim.com/news/view/20180704000371
483,2018-07-04,부광약품이달내당뇨신약2상후기환자모집종료”,http://www.newsway.co.kr/view.php?tp=1&ud=2018070415193992909
484,2018-07-04,부광약품당뇨병신약임상2상환자모집완료,http://news.heraldcorp.com/view.php?ud=20180704000651
485,2018-07-04,부광약품3조원예상당뇨병신약2상후기환자모집종료임박,http://www.getnews.co.kr/news/articleView.html?idxno=80901
486,2018-07-04,부광약품당뇨병신약2상후기환자모집7월내완료예상,http://www.mdtoday.co.kr/mdtoday/index.html?no=325751
487,2018-07-04,부광약품당뇨병신약임상2b상7월중환자모집완료”,http://biz.chosun.com/site/data/html_dir/2018/07/04/2018070402586.html
488,2018-07-04,부광약품이달당뇨병신약임상환자모집완료예정,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018070415164758713
489,2018-07-04,부광약품당뇨병신약2상후기환자모집이달종료,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807040503&t=NN
490,2018-07-04,부광약품당뇨신약개발드라이브,http://www.monews.co.kr/news/articleView.html?idxno=116523
491,2018-07-04,부광약품당뇨병신약MLR10232상후기환자모집완료,http://jedam15.koreafree.co.kr/news/view.html?section=1&category=3&item=&no=42265
492,2018-07-04,부광약품당뇨병신약MLR10232상후기환자모집완료임박,http://www.etoday.co.kr/news/section/newsview.php?idxno=1638165
493,2018-07-04,부광약품당뇨병신약오는11월2상후기임상완료,http://sports.hankooki.com/lpage/life/201807/sp20180704170010136800.htm
494,2018-07-04,부광약품당뇨신약임상2상후기환자모집이달말종료,http://news.mk.co.kr/newsRead.php?year=2018&no=421799
495,2018-07-04,부광약품당뇨병신약MLR1023개발박차,http://www.rapportian.com/news/articleView.html?idxno=111475
496,2018-07-04,부광약품당뇨병신약환자모집완료전망예상매출3조원,http://www.econovill.com/news/articleView.html?idxno=340973
497,2018-07-05,부광약품이주목받는이유오픈이노베이션효과,http://medipana.com/news/news_viewer.asp?NewsNum=222300&MainKind=A&NewsKind=5&vCount=12&vKind=1
498,2018-07-05,부광약품당뇨신약MLR1023임상순항중,http://www.bosa.co.kr/news/articleView.html?idxno=2086114
499,2018-07-05,부광약품당뇨신약임상2상후기환자모집마무리단계,http://www.finomy.com/news/articleView.html?idxno=56005
500,2018-07-05,부광약품7월15일일까지각부문신입및경력채용,http://www.ekn.kr/news/article.html?no=372477
501,2018-07-06,부광약품당뇨병신약MLR10232상후기환자모집완료예상,http://www.kpanews.co.kr/article/show.asp?idx=195168&table=article&category=D
502,2018-07-06,부광약품㈜각부문신입및경력사원모집7월15일채용마감,http://www.ekn.kr/news/article.html?no=372647
503,2018-07-09,더벨부광약품덴마크자회사코스닥상장추진,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201807060100010790000671
504,2018-07-09,고혈압치료제서발암물질검출셀트리온부광약품환인제약등제약업계초비상,http://www.iminju.net/news/articleView.html?idxno=36748
505,2018-07-09,광동제약코오롱제약부광약품등46개사104개품목판매중지해제이유는,http://medicalworldnews.co.kr/news/view.php?idx=1510926466
506,2018-07-13,부광약품투자美바이오벤처에이서희귀의약품개발막바지,http://news.mk.co.kr/newsRead.php?year=2018&no=441918
507,2018-07-16,CEO스토리유희원부광약품대표실험실박차고경영의길로신약개발서영업까지훤히꿰뚫죠,http://www.sedaily.com/NewsView/1S23WKXC6D
508,2018-07-18,베스트리포트부광약품신약개발순항중,http://news.mt.co.kr/mtview.php?no=2018071810102312130
509,2018-07-19,신약개발사활건제약사부광약품오픈이노베이션통해6개글로벌신약개발중,http://www.sedaily.com/NewsView/1S259OQCOZ
510,2018-07-24,더벨부광약품오너2세들주식공탁연부연납이행,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201807230100040110002535
511,2018-07-24,부광약품자회사콘테라파마등상장계획,http://news.hankyung.com/article/2018072431386
512,2018-07-24,부광약품투자신약개발업체3곳상장추진,http://www.dailypharm.com/News/242145
513,2018-07-24,부광약품자회사콘테라파마등3곳상장추진,http://www.etoday.co.kr/news/section/newsview.php?idxno=1644887
514,2018-07-24,부광약품신약개발자회사들차례로상장계획,http://www.newspim.com/news/view/20180724000383
515,2018-07-24,부광약품다이나세라퓨틱스등자회사코스닥상장추진,http://biz.chosun.com/site/data/html_dir/2018/07/24/2018072401480.html
516,2018-07-24,부광약품콘테라파마다이나세라퓨틱스등자회사상장계획,http://www.mdtoday.co.kr/mdtoday/index.html?no=327575
517,2018-07-24,부광약품신약개발자회사3곳상장추진,http://medipana.com/news/news_viewer.asp?NewsNum=223122&MainKind=A&NewsKind=5&vCount=12&vKind=1
518,2018-07-24,부광약품자회사3곳잇따라상장추진,http://www.newsis.com/view/?id=NISX20180724_0000372602&cID=13001&pID=13000
519,2018-07-24,부광약품자회사콘테라파마OCI합작사등상장추진,http://www.medisobizanews.com/news/articleView.html?idxno=54387
520,2018-07-24,부광약품신약개발자회사3곳상장추진,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018072415130702509&LinkID=632&objId=A2018072415130702509&portalCode=naver
521,2018-07-24,투자는나의힘부광약품자회사상장예고,http://www.monews.co.kr/news/articleView.html?idxno=117306
522,2018-07-24,부광약품신약개발자회사3곳상장추진,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807240492&t=NN
523,2018-07-24,부광약품벤처투자후상장전략이어갈것,http://news.mk.co.kr/newsRead.php?year=2018&no=465280
524,2018-07-24,부광약품신약개발중인자회사3곳상장계획,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018072415050367276
525,2018-07-24,부광약품자회사3곳잇따라상장추진,http://www.getnews.co.kr/news/articleView.html?idxno=85576
526,2018-07-24,부광약품다이나세라퓨틱스상장추진,http://www.finomy.com/news/articleView.html?idxno=56560
527,2018-07-24,부광약품신약개발사인큐베이터자처다음타자는,http://www.medicaltimes.com/News/1120086
528,2018-07-24,부광약품신약개발자회사3곳상장추진,http://www.dailymedi.com/detail.php?number=832893&thread=22r05
529,2018-07-24,ET투자뉴스안트로젠지분변동부광약품주외3명201p감소2178보유,http://www.etnews.com/20180724000392
530,2018-07-24,부광약품다이나세라퓨틱스등자회사상장추진,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1058481
531,2018-07-25,부광약품투자사자회사연이어상장추진성장동력확보,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=220516
532,2018-07-25,컨콜이우현사장부광약품과합작사비앤오바이오설립”,http://www.newsway.co.kr/news/view?tp=1&ud=2018072516563453109
533,2018-07-25,안트로젠최대주주부광약품일가277억원대주식처분,http://www.mdtoday.co.kr/mdtoday/index.html?no=327727
534,2018-07-25,OCI바이오시장진출본격화부광약품과합작사설립,http://www.dailian.co.kr/news/view/728502/?sc=naver
535,2018-07-25,부광약품자회사다이나세라퓨틱스등상장계획재무구조더욱견고해질것,http://www.insight.co.kr/news/168233
536,2018-07-26,더벨IRBriefingOCI부광약품과손잡고바이오산업진출,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201807250100046490002916
537,2018-07-26,부광약품김동연회장자녀들보유주식담보혹은법원공탁승계작업분주,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=526781
538,2018-07-31,투자이끌어파이프라인확대보령제약부광약품자회사상장추진,http://biz.newdaily.co.kr/site/data/html/2018/07/31/2018073100091.html
539,2018-08-02,부광약품美투자사지분매각통해FDA승인예상되는주력신약상업화준비,http://www.nspna.com/news/?mode=view&newsid=297495
540,2018-08-06,더벨부광약품OCI합작법인오너들이직접챙긴다,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201808020100003380000220
541,2018-08-07,부광약품당뇨병신약임상시험환자등록완료,http://www.edaily.co.kr/news/newspath.asp?newsid=01899126619305024
542,2018-08-07,부광약품2형당뇨병신약한미후기2상환자등록완료,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=220931
543,2018-08-07,부광약품당뇨병신약MLR1023임상2b상환자등록완료,http://news.hankyung.com/article/2018080771906
544,2018-08-07,부광약품당뇨병치료신약MLR1023후기2상환자등록완료,http://www.etoday.co.kr/news/section/newsview.php?idxno=1649844
545,2018-08-07,부광약품당뇨신약후기2상환자등록완료,http://medipana.com/news/news_viewer.asp?NewsNum=223687&MainKind=A&NewsKind=5&vCount=12&vKind=1
546,2018-08-07,부광약품당뇨병치료신약후기2상환자등록,http://www.newsis.com/view/?id=NISX20180807_0000384269&cID=13001&pID=13000
547,2018-08-07,부광약품당뇨병신약MLR1023후기2상환자등록완료,http://www.newsway.co.kr/news/view?tp=1&ud=2018080709362272076
548,2018-08-07,부광약품韓美서당뇨병신약2상환자등록마쳐,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1058985
549,2018-08-07,DailyPharma부광약품당뇨병치료신약임상2상환자등록완료,http://www.econovill.com/news/articleView.html?idxno=343303
550,2018-08-07,부광약품당뇨병치료신약후기임상2상환자등록완료,http://www.newspim.com/news/view/20180807000146
551,2018-08-07,부광약품제2형당뇨병치료신약MLR1023후기2상환자등록완료,http://www.getnews.co.kr/news/articleView.html?idxno=88428
552,2018-08-07,부광약품당뇨병치료신약후기2상환자등록완료,http://www.medicaltimes.com/News/1120341
553,2018-08-07,부광약품제2형당뇨병치료신약후기2상에환자400명등록,http://www.medisobizanews.com/news/articleView.html?idxno=54636
554,2018-08-07,부광약품당뇨병신약임상시험환자등록완료,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018080710241733350
555,2018-08-07,부광약품당뇨병치료제신약2상환자등록완료,http://www.rapportian.com/news/articleView.html?idxno=112109
556,2018-08-07,부광약품당뇨병신약임상2상환자400명등록완료,http://biz.chosun.com/site/data/html_dir/2018/08/07/2018080700950.html
557,2018-08-07,부광약품당뇨병신약후기2상환자등록완료,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808070185&t=NN
558,2018-08-07,부광약품당뇨신약2상임상환자등록완료,http://www.monews.co.kr/news/articleView.html?idxno=117777
559,2018-08-07,부광약품당뇨신약후기2상환자등록완료,http://news.hankyung.com/article/201808077800f
560,2018-08-07,부광약품제2형당뇨병치료신약후기2상환자등록완료,http://www.mdtoday.co.kr/mdtoday/index.html?no=328862
561,2018-08-07,부광약품당뇨신약MLR10232상환자등록마쳐,http://www.sedaily.com/NewsView/1S39OCCZBD
562,2018-08-07,부광약품당뇨병신약MLR1023후기2상임상시험환자등록완료,http://news.mk.co.kr/newsRead.php?year=2018&no=494482
563,2018-08-07,부광약품당뇨신약후기임상2상본격화,http://www.finomy.com/news/articleView.html?idxno=56953
564,2018-08-09,부광약품생약성분함유간기능개선제레가리버350연질캡슐출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=221029
565,2018-08-09,부광약품생약성분간기능개선제레가리버출시,http://www.medisobizanews.com/news/articleView.html?idxno=54696
566,2018-08-09,부광약품간기능개선제레가리버350출시,http://medipana.com/news/news_viewer.asp?NewsNum=223814&MainKind=A&NewsKind=5&vCount=12&vKind=1
567,2018-08-09,부광약품생약성분함유간기능개선제레가리버출시,http://www.medicaltimes.com/News/1120404
568,2018-08-09,부광약품생약성분함유간기능개선제레가리버350연질캡슐출시,http://www.getnews.co.kr/news/articleView.html?idxno=88874
569,2018-08-09,부광약품간기능개선제레가리버출시,http://www.rapportian.com/news/articleView.html?idxno=112158
570,2018-08-09,부광약품간기능개선제레가리버350출시,http://www.whosaeng.com/sub_read.html?uid=103499§ion=sc5
571,2018-08-09,부광약품간기능개선제레가리버발매,http://www.kpinews.co.kr/news/articleView.html?idxno=79110
572,2018-08-10,부광약품생약성분함유간개선제레가리버출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1059142
573,2018-08-14,부광약품항암제리보세라닙판권등400억에양도,http://news.mt.co.kr/mtview.php?no=2018081414333505068
574,2018-08-14,부광약품에이치엘비생명과학에리보세라닙국내판매권등400억원에양도,http://view.asiae.co.kr/news/view.htm?idxno=2018081414400520884
575,2018-08-14,공시부광약품HLB생명과학에표적항암제개발판매권등400억에양도,http://www.newsway.co.kr/news/view?tp=1&ud=2018081414404716369
576,2018-08-14,부광약품항암제리보세라닙판권에이치엘비에양도,http://www.edaily.co.kr/news/newspath.asp?newsid=04122966619307320
577,2018-08-14,부광약품HLB생명과학에리보세라닙판매권등양도,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180814108300008&did=1195m
578,2018-08-14,부광약품개발중항암제에이치엘비생명과학에양도계약금400억원,http://www.ceoscoredaily.com/news/article.html?no=44699
579,2018-08-14,부광약품에이치엘비생명과학에리보세라닙판권등400억에양도,http://www.newsis.com/view/?id=NISX20180814_0000390696&cID=10401&pID=10400
580,2018-08-14,에이치엘비생명부광약품리보세라닙권리400억양수도,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=221175
581,2018-08-14,공시부광약품표적항암제개발판매권400억원에양도,http://moneys.mt.co.kr/news/mwView.php?no=2018081414518046552
582,2018-08-14,부광약품에이치엘비에리보세라닙권리양도하고400억원받기로,http://news.mk.co.kr/newsRead.php?year=2018&no=509862
583,2018-08-14,부광약품항암제리보세라닙판매권등400억에양도,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018081414490628786
584,2018-08-14,공시부광약품에이치엘비생명과학에리보세라닙판매권등양도400억원규모,http://www.g-enews.com/ko-kr/news/article/news_all/201808141454105669c642673384_1/article.html
585,2018-08-14,부광약품항암제리보세라닙권리400억원에에이치엘비에넘겨,http://www.sedaily.com/NewsView/1S3CWL9PCL
586,2018-08-14,부광약품에이치엘비생명과학에리보세라닙판권일부양도,http://www.newsprime.co.kr/news/article.html?no=426378
587,2018-08-14,부광약품에이치엘비생명과학에리보세라닙양수,http://www.kpinews.co.kr/news/articleView.html?idxno=79372
588,2018-08-14,공시에이치엘비생명과학400억규모부광약품보유리보세라닙권리양수,http://view.asiae.co.kr/news/view.htm?idxno=2018081415072949545
589,2018-08-14,부광약품에이치엘비생명과학에함암제리보세라닙권리400억원에양도,http://www.businesskorea.co.kr/news/articleView.html?idxno=24306
590,2018-08-14,부광약품에이치엘비에항암제리보세라닙권리양도,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808140439&t=NN
591,2018-08-14,부광약품위암치료제리보세라닙400억에양도,http://medipana.com/news/news_viewer.asp?NewsNum=223980&MainKind=A&NewsKind=5&vCount=12&vKind=1
592,2018-08-14,부광약품에이치엘비생명과학라보세라닙권리400억에양수도,http://www.mdtoday.co.kr/mdtoday/index.html?no=329513
593,2018-08-14,부광약품에이치엘비에400억원받고리보세라닙권리넘겨,http://www.newstomato.com/ReadNews.aspx?no=841428
594,2018-08-14,특징주부광약품신약파이프라인계약체결주가기지개펴나,http://www.g-enews.com/ko-kr/news/article/news_all/201808141519302233c642673384_1/article.html
595,2018-08-14,항암신약물질리보세라닙권리부광약품→에이치엘비생과양도,http://news1.kr/articles/?3398459
596,2018-08-14,부광약품에이치엘비생명과학에표적항암제권리양도,http://www.newspim.com/news/view/20180814000808
597,2018-08-14,부광약품리보세라닙권리400억에에이치엘비로양도,http://www.etoday.co.kr/news/section/newsview.php?idxno=1652752
598,2018-08-14,부광약품HLB생명과학에리보세라닙판매권등양도종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180814108351008&did=1195m
599,2018-08-14,부광약품HLB생명과학과400억원에항암제권리양도,http://biz.chosun.com/site/data/html_dir/2018/08/14/2018081401867.html
600,2018-08-14,부광약품에이치엘비생명과학에신약후보물질400억원에양도,http://www.edaily.co.kr/news/newspath.asp?newsid=05051206619307320
601,2018-08-14,부광약품리보세라닙400억원에권리양도,http://www.medical-tribune.co.kr/news/articleView.html?idxno=80773
602,2018-08-14,부광약품표적항암제리보세라닙권리400억원대양도,http://www.medisobizanews.com/news/articleView.html?idxno=54783
603,2018-08-14,부광약품∙에이치엘비생명과학리보세라닙권리400억원에양수도,http://www.getnews.co.kr/news/articleView.html?idxno=89845
604,2018-08-14,부광약품400억원규모신약파이프라인계약,http://www.econovill.com/news/articleView.html?idxno=343817
605,2018-08-14,부광약품400억원에리보세라닙권리이전,http://www.bosa.co.kr/news/articleView.html?idxno=2088391
606,2018-08-14,부광약품에이치엘비생명과학에리보세라닙권리400억원에양도,http://www.medigatenews.com/news/3129961066
607,2018-08-14,부광약품HLB생명과학에신약후보물질권리400억에양도,http://www.newsway.co.kr/news/view?tp=1&ud=2018081416392623906
608,2018-08-14,부광약품에이치엘비에리보세라닙권리400억에양도,http://www.newsis.com/view/?id=NISX20180814_0000390867&cID=13001&pID=13000
609,2018-08-14,부광약품HLB생명과학에항암제개발판매권양도,http://www.edaily.co.kr/news/newspath.asp?newsid=05333286619307320
610,2018-08-14,부광약품에이치엘비생명과학과양도계약체결,http://www.nspna.com/news/?mode=view&newsid=299893
611,2018-08-14,부광약품에이치엘비생명과학에리보세라닙400억에양도,http://www.rapportian.com/news/articleView.html?idxno=112256
612,2018-08-14,부광약품자사리보세라닙권리400억원에양수,http://www.medicaltimes.com/News/1120496
613,2018-08-14,부광약품에이치엘비생명과학에항암제리보세라닙판권양도,http://www.ajunews.com/view/20180814170052306
614,2018-08-14,실적속보부광약품2Q영업이익37억전년비1077↑,http://www.itooza.com/common/iview.php?no=2018081420063464275
615,2018-08-14,부광약품2분기연결영업이익37억전년비1077↑,http://www.newspim.com/news/view/20180814001264
616,2018-08-14,유가증권기업공시14일부광약품등,http://news.hankyung.com/article/2018081428531
617,2018-08-15,부광약품에이치엘비생명과학에리보세라닙권리400억에양도,http://www.econonews.co.kr/news/articleView.html?idxno=32634
618,2018-08-16,부광약품400억원규모파이프라인계약,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1059283
619,2018-08-16,부광약품에이치엘비생명과학에리보세라닙양수도,http://www.monews.co.kr/news/articleView.html?idxno=118037
620,2018-08-16,공시부광약품에이치엘비에리보세라닙개발및판매권양도,http://www.newsway.co.kr/news/view?tp=1&ud=2018081613013579974
621,2018-08-16,부광약품400억에항암제리보세라닙개발판권양도,http://news.mt.co.kr/mtview.php?no=2018081613020228216
622,2018-08-16,부광약품400억규모리보세라닙국내판권양도,http://www.edaily.co.kr/news/newspath.asp?newsid=03952406619307976
623,2018-08-16,부광약품에이치엘비생명과학에경구용표적항암제개발판권양도,http://www.etoday.co.kr/news/section/newsview.php?idxno=1653288
624,2018-08-16,부광약품항암제리보세라닙400억에개발판권양도,http://www.mdtoday.co.kr/mdtoday/index.html?no=329676
625,2018-08-16,부광약품400억원항암제리보세라닙개발판권양도,http://view.asiae.co.kr/news/view.htm?idxno=2018081613272391524
626,2018-08-16,에이치엘비생명과학부광약품항암제리보세라닙400억에양수,http://www.etoday.co.kr/news/section/newsview.php?idxno=1653297
627,2018-08-16,부광약품에이치엘비생명과학에리보세라닙개발판매권양도,http://www.sedaily.com/NewsView/1S3DSWRZXQ
628,2018-08-16,KDDF지원한부광약품과제에이치엘비생명과학과400억원규모양수도계약체결,http://www.fnnews.com/news/201808161515038140
629,2018-08-16,에이치엘비생명과학400억원에리보세라닙개발판권부광약품으로부터양수,http://www.econonews.co.kr/news/articleView.html?idxno=32802
630,2018-08-16,부광약품에이치엘비생명과학에리보세라닙개발판권양도,http://www.newspim.com/news/view/20180816000581
631,2018-08-16,부광약품에이치엘비리보세라닙400억양수도계약체결,http://www.kormedi.com/news/news/drug_dist/1228779_2906.html
632,2018-08-16,유가증권시장공시키움증권부광약품일성건설,http://news.mk.co.kr/newsRead.php?year=2018&no=514836
633,2018-08-16,유가증권기업공시16일부광약품등,http://news.hankyung.com/article/2018081692241
634,2018-08-17,더벨부광약품해외바이오투자성과쏠쏠하네,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201808160100025750001624
635,2018-08-21,부광약품자산재평가실시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1654784
636,2018-08-21,부광약품본사공장토지자산재평가실시,http://view.asiae.co.kr/news/view.htm?idxno=2018082116345180894
637,2018-08-21,부광약품본사및연구소동공장토지재평가실시,http://www.newsis.com/view/?id=NISX20180821_0000396259&cID=10401&pID=10400
638,2018-08-21,부광약품본사공장자산재평가실시,http://www.edaily.co.kr/news/newspath.asp?newsid=03785126619309616
639,2018-08-21,부광약품본사및공장등토지재평가실시자산의실질가치반영,http://www.econonews.co.kr/news/articleView.html?idxno=33392
640,2018-08-22,부광약품149억규모본사공장부동산자산재평가실시,http://www.mdtoday.co.kr/mdtoday/index.html?no=330156
641,2018-08-24,RD톺아보기부광약품버추얼랩중심신약개발로위험부담줄여,http://www.etoday.co.kr/news/section/newsview.php?idxno=1655825
642,2018-08-24,부광약품안트로젠주식40만주양도예정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1656019
643,2018-08-24,부광약품안트로젠주식408억원어치양도결정,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180824141200008&did=1195m
644,2018-08-24,공시부광약품안트로젠주식408억원어치양도결정,http://www.newsway.co.kr/news/view?tp=1&ud=2018082417431905821
645,2018-08-24,공시부광약품안트로젠주식408억원어치양도결정,http://www.fnnews.com/news/201808241750472259
646,2018-08-24,부광약품안트로젠주식40만주408억에처분,http://www.dailypharm.com/News/243099
647,2018-08-24,부광약품안트로젠주식40만주양도결정,http://www.nspna.com/news/?mode=view&newsid=302071
648,2018-08-24,부광약품안트로젠주식40만주408억원에양도,http://view.asiae.co.kr/news/view.htm?idxno=2018082418152045974
649,2018-08-24,부광약품자회사안트로젠주식408억원어치양도,http://medipana.com/news/news_viewer.asp?NewsNum=224396&MainKind=A&NewsKind=5&vCount=12&vKind=1
650,2018-08-27,부광약품안트로젠주식40만주408억양도결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=330543
651,2018-08-28,더벨부광약품안트로젠잇단매도이성구대표홀로서기,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201808270100044830002830
652,2018-08-29,최명성의바닥탈출실적성장세에수급호조까지부광약품,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018082909401194291
653,2018-08-29,부광약품5거래일연속상승전일대비3상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808290320&t=NN
654,2018-08-30,기자의눈영업익77억부광약품의RD생존법,http://www.dailypharm.com/News/243182
655,2018-08-30,투명경영하려고700억원세금다낸납세왕부광약품회장님,http://www.insight.co.kr/news/175512
656,2018-09-05,빅데이터주식투자코스피부광약품,http://www.leaders.kr/news/articleView.html?idxno=74042
657,2018-09-06,증시현황6일부광약품주가오전10시13분25800원,http://www.anewsa.com/detail.php?number=1367561&thread=10r04
658,2018-09-06,ET투자뉴스안트로젠지분변동부광약품주외1명307p감소1871보유,http://www.etnews.com/20180906000316
659,2018-09-06,부광약품자산재평가로토지자산601억증가,http://view.asiae.co.kr/news/view.htm?idxno=2018090616540552470
660,2018-09-06,공시부광약품본사공장자산재평가결과150억→750억,http://www.newsway.co.kr/news/view?tp=1&ud=2018090616534785309
661,2018-09-06,부광약품기존150억원토지자산재평가통해751억원으로상승,http://www.etoday.co.kr/news/section/newsview.php?idxno=1660901
662,2018-09-06,부광약품토지재평가로601억원차액발생,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180906149900008&did=1195m
663,2018-09-06,부광약품서울본사안산공장자산재평가실시,http://www.edaily.co.kr/news/newspath.asp?newsid=04004886619337496
664,2018-09-06,부광약품본사안산공장자산재평가149억→751억원,http://www.sedaily.com/NewsView/1S4J5KN0SZ
665,2018-09-07,부광약품서울본사및안산공장자산재평가150억→751억,http://www.mdtoday.co.kr/mdtoday/index.html?no=331724
666,2018-09-07,증시현황7일부광약품주가오전9시39분26550원,http://www.anewsa.com/detail.php?number=1368470&thread=10r04
667,2018-09-07,마감증시보고부광약품9월7일27000원마감,http://www.anewsa.com/detail.php?number=1369062&thread=10r04
668,2018-09-10,더벨부광약품오너일가안트로젠엑시트완료,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201809070100010790000674
669,2018-09-10,증시현황10일부광약품주가오전9시35분26550원,http://www.anewsa.com/detail.php?number=1369713&thread=10r04
670,2018-09-10,부광약품오너일가안트로젠주식매도로31배차익실현,http://www.mdtoday.co.kr/mdtoday/index.html?no=331975
671,2018-09-10,마감증시보고부광약품9월10일26350원으로종료,http://www.anewsa.com/detail.php?number=1370504&thread=10r04
672,2018-09-11,증시현황11일부광약품주가오전10시20분26600원,http://www.anewsa.com/detail.php?number=1370904&thread=10r04
673,2018-09-11,마감증시보고부광약품9월11일26700원마감,http://www.anewsa.com/detail.php?number=1371431&thread=10r04
674,2018-09-12,증시현황12일부광약품주가오전10시20분26850원,http://www.anewsa.com/detail.php?number=1372085&thread=10r04
675,2018-09-12,마감증시보고부광약품9월12일26750원으로종료,http://www.anewsa.com/detail.php?number=1372856&thread=10r04
676,2018-09-14,증시현황14일부광약품주가오후12시06분26750원,http://www.anewsa.com/detail.php?number=1374559&thread=10r04
677,2018-09-14,마감증시보고부광약품9월14일26800원마감,http://www.anewsa.com/detail.php?number=1375103&thread=10r04
678,2018-09-17,더벨부광약품오너2세가증여에대처하는법,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201809140100023580001465
679,2018-09-17,증시현황17일부광약품주가오후12시06분26700원,http://www.anewsa.com/detail.php?number=1376001&thread=10r04
680,2018-09-17,마감증시보고부광약품9월17일26750원장마쳐,http://www.anewsa.com/detail.php?number=1376594&thread=10r04
681,2018-09-18,부광약품활성비타민보강메가바이액티브정출시,http://www.dailypharm.com/News/243883
682,2018-09-18,부광약품메가바이액티브정,http://www.medical-tribune.co.kr/news/articleView.html?idxno=81324
683,2018-09-18,부광약품활성비타민메가바이액티브정출시,http://www.rapportian.com/news/articleView.html?idxno=112980
684,2018-09-18,부광약품활성비타민보강고함량메가바이액티브정출시,http://www.medisobizanews.com/news/articleView.html?idxno=55383
685,2018-09-18,부광약품활성비타민보강메가바이액티브정출시,http://www.getnews.co.kr/news/articleView.html?idxno=96216
686,2018-09-19,19일부광약품주가오전11시55분26950원,http://www.anewsa.com/detail.php?number=1378071&thread=10r04
687,2018-09-19,부광약품활성비타민메가바이액티브정출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1060581
688,2018-09-19,부광약품9월19일26750원으로마감,http://www.anewsa.com/detail.php?number=1378880&thread=10r04
689,2018-09-20,부광약품신약후보물질가치상승투자유망골든브릿지,http://news.hankyung.com/article/2018092041656
690,2018-09-20,20일부광약품주가오전11시05분27350원,http://www.anewsa.com/detail.php?number=1379263&thread=10r04
691,2018-09-20,부광약품주가27250원으로종료,http://www.anewsa.com/detail.php?number=1380156&thread=10r04
692,2018-09-21,부광약품아스타잔틴함유눈건강기능식품출시,http://medipana.com/news/news_viewer.asp?NewsNum=225662&MainKind=A&NewsKind=5&vCount=12&vKind=1
693,2018-09-21,부광약품눈피로개선눈건강아스타잔틴출시,http://www.getnews.co.kr/news/articleView.html?idxno=96689
694,2018-09-21,부광약품눈피로개선건강기능식품아스타잔틴출시,http://www.medisobizanews.com/news/articleView.html?idxno=55443
695,2018-09-21,21일부광약품주가오전11시06분27300원,http://www.anewsa.com/detail.php?number=1380532&thread=10r04
696,2018-09-21,부광약품눈건강아스타잔틴출시,http://www.bosa.co.kr/news/articleView.html?idxno=2090746
697,2018-09-21,부광약품눈건강기능식품아스타잔틴출시,http://www.rapportian.com/news/articleView.html?idxno=113062
698,2018-09-21,부광약품눈영양제아스타잔틴출시,http://www.dailypharm.com/News/244035
699,2018-09-21,부광약품주가27350원마감해,http://www.anewsa.com/detail.php?number=1381223&thread=10r04
700,2018-09-27,27일부광약품주가오전11시06분27400원,http://www.anewsa.com/detail.php?number=1382161&thread=10r04
701,2018-09-27,부광약품주가27400원마감,http://www.anewsa.com/detail.php?number=1382933&thread=10r04
702,2018-09-28,28일부광약품주가오전11시06분27650원,http://www.anewsa.com/detail.php?number=1383227&thread=10r04
703,2018-09-28,부광약품주가27600원장마쳐,http://www.anewsa.com/detail.php?number=1383899&thread=10r04
704,2018-10-01,1일부광약품주가오전11시07분26900원,http://www.anewsa.com/detail.php?number=1384496&thread=10r04
705,2018-10-02,2일부광약품주가오전11시06분26150원,http://www.anewsa.com/detail.php?number=1385574&thread=10r04
706,2018-10-02,ET투자뉴스안트로젠지분변동부광약품주257p감소1614보유,http://www.etnews.com/20181002000222
707,2018-10-02,부광약품주가26250원마감,http://www.anewsa.com/detail.php?number=1386323&thread=10r04
708,2018-10-04,4일부광약품주가오전11시06분25850원,http://www.anewsa.com/detail.php?number=1386789&thread=10r04
709,2018-10-04,안트로젠주식처분나선부광약품,http://www.mdtoday.co.kr/mdtoday/index.html?no=334055
710,2018-10-04,부광약품주가26200원으로마감,http://www.anewsa.com/detail.php?number=1387639&thread=10r04
711,2018-10-04,부광약품안트로젠투자금회수에속도201억원추가처분,http://www.etoday.co.kr/news/section/newsview.php?idxno=1669913
712,2018-10-05,안트로젠지분파는부광약품家최대주주뒤바뀌어,http://news.hankyung.com/article/2018100571261
713,2018-10-05,부광약품주가25850원마감해,http://www.anewsa.com/detail.php?number=1388489&thread=10r04
714,2018-10-08,부광약품떠나홀로서기나선안트로젠윈윈모델,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1061068
715,2018-10-08,부광약품주가25200원마감해,http://www.anewsa.com/detail.php?number=1389894&thread=10r04
716,2018-10-10,10일부광약품주가오전11시05분24950원,http://www.anewsa.com/detail.php?number=1390462&thread=10r04
717,2018-10-11,부광약품전일대비약6하락한23450원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810110516&t=NN
718,2018-10-11,부광약품주가22950원으로종료,http://www.anewsa.com/detail.php?number=1392354&thread=10r04
719,2018-10-12,12일부광약품주가오전11시06분23500원,http://www.anewsa.com/detail.php?number=1392675&thread=10r04
720,2018-10-14,부광약품외부자금실탄확보신약개발총력,http://www.edaily.co.kr/news/newspath.asp?newsid=01174246619372920
721,2018-10-15,15일부광약품주가오전11시06분23650원,http://www.anewsa.com/detail.php?number=1394163&thread=10r04
722,2018-10-15,신약파이프라인가치상승에주목받는부광약품,http://www.mdtoday.co.kr/mdtoday/index.html?no=335237
723,2018-10-15,부광약품주가23450원으로장마감,http://www.anewsa.com/detail.php?number=1394959&thread=10r04
724,2018-10-16,부광약품총자산5천억원이상신약개발강화,http://www.medical-tribune.co.kr/news/articleView.html?idxno=81808
725,2018-10-16,유희원사장부광약품RD성과로총자산5천억상회,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=223086
726,2018-10-16,58돌부광약품RD성과로총자산5천억대도약,http://www.medicaltimes.com/News/1121709
727,2018-10-16,부광약품창립58주년RD성과로총자산5000억이상기대,http://www.medisobizanews.com/news/articleView.html?idxno=55784
728,2018-10-16,부광약품창립58주년기념식거행,http://www.getnews.co.kr/news/articleView.html?idxno=100449
729,2018-10-16,부광약품창립58주년당뇨파킨슨신약순항,http://medipana.com/news/news_viewer.asp?NewsNum=226707&MainKind=A&NewsKind=5&vCount=12&vKind=1
730,2018-10-16,부광약품창립58주년맞아신약RD로선순환구조구축,http://www.rapportian.com/news/articleView.html?idxno=113462
731,2018-10-16,부광약품주가23600원마감해,http://www.anewsa.com/detail.php?number=1395789&thread=10r04
732,2018-10-17,글로벌Biz24부광약품당뇨신약임상2b환자등록완료3조원혁신신약개발박차,http://www.g-enews.com/ko-kr/news/article/news_all/20181017110029812725b4ac5ede_1/article.html
733,2018-10-17,부광약품주가23700원으로종료,http://www.anewsa.com/detail.php?number=1397031&thread=10r04
734,2018-10-18,18일부광약품주가오전11시05분24350원,http://www.anewsa.com/detail.php?number=1397371&thread=10r04
735,2018-10-18,부광약품나딕사발매10주년기념심포지엄개최,http://medipana.com/news/news_viewer.asp?NewsNum=226835&MainKind=A&NewsKind=5&vCount=12&vKind=1
736,2018-10-18,부광약품나딕사10주년기념심포지엄개최,http://www.medicaltimes.com/News/1121771
737,2018-10-18,부광약품나딕사병용처방유효하고여드름치료효과적,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=223197
738,2018-10-18,부광약품나딕사출시10주년심포지엄,http://www.whosaeng.com/sub_read.html?uid=105266§ion=sc5
739,2018-10-18,부광약품나딕사여드름예방치료에효과,http://kormedi.com/?p=1252296
740,2018-10-18,부광약품나딕사광범위한항균효과부작용도낮아,http://www.medisobizanews.com/news/articleView.html?idxno=55825
741,2018-10-18,부광약품나딕사출시10주년기념심포지엄열어,http://www.kpanews.co.kr/article/show.asp?idx=197895&table=article&category=D
742,2018-10-18,부광약품나딕사10주년기념심포지엄개최,http://www.getnews.co.kr/news/articleView.html?idxno=100888
743,2018-10-19,부광약품나딕사런칭10주년심포지엄,http://www.dailypharm.com/News/244905
744,2018-10-19,부광약품나딕사출시10주년심포지엄개최,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1061426
745,2018-10-19,부광약품나딕사10주년기념심포지엄개최,http://www.bosa.co.kr/news/articleView.html?idxno=2092255
746,2018-10-19,부광약품나딕사10주년기념심포지엄성료,http://www.dailymedi.com/detail.php?number=835880&thread=22r05
747,2018-10-19,부광약품나딕사10주년기념심포지엄개최,http://www.100ssd.co.kr/news/articleView.html?idxno=56925
748,2018-10-19,부광약품나딕사10주년심포지엄개최,http://www.monews.co.kr/news/articleView.html?idxno=120404
749,2018-10-19,ET투자뉴스안트로젠지분변동부광약품주192p감소1422보유,http://www.etnews.com/20181019000288
750,2018-10-19,19일부광약품주가24450원,http://www.anewsa.com/detail.php?number=1398628&thread=10r04
751,2018-10-20,부광약품두달새377억규모안트로젠주식처분,http://www.dailypharm.com/News/244986
752,2018-10-22,부광약품신제품네오메드치약출시홈쇼핑서첫판매,http://www.newspim.com/news/view/20181022000063
753,2018-10-22,부광약품신제품네오메드치약발매첫홈쇼핑방송,http://www.edaily.co.kr/news/newspath.asp?newsid=01826966619375544
754,2018-10-22,부광약품네오메드치약발매첫홈쇼핑방송,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=223280
755,2018-10-22,부광약품네오메드치약첫홈쇼핑온에어,http://www.dailypharm.com/News/245033
756,2018-10-22,부광약품치주질환예방시린이억제치약출시,http://medipana.com/news/news_viewer.asp?NewsNum=226976&MainKind=A&NewsKind=5&vCount=12&vKind=1
757,2018-10-22,부광약품네오메드치약발매첫홈쇼핑방송,http://www.sisajournal-e.com/biz/article/190467
758,2018-10-22,부광약품네오메드치약발매홈쇼핑방송,http://www.bosa.co.kr/news/articleView.html?idxno=2092363
759,2018-10-22,부광약품신제품네오메드치약발매홈쇼핑첫방송,http://www.etoday.co.kr/news/section/newsview.php?idxno=1676783
760,2018-10-22,부광약품네오메드치약홈쇼핑서판매,http://www.rapportian.com/news/articleView.html?idxno=113565
761,2018-10-22,22일부광약품주가24450원,http://www.anewsa.com/detail.php?number=1399917&thread=10r04
762,2018-10-22,부광약품신제품네오메드치약발매첫홈쇼핑방송,http://www.getnews.co.kr/news/articleView.html?idxno=101430
763,2018-10-22,부광약품JM010유럽임상2상승인,http://www.newspim.com/news/view/20181022000256
764,2018-10-22,부광약품이상운동증신약JM010유럽2상승인,http://www.medicaltimes.com/News/1121860
765,2018-10-22,부광약품네오메드치약홈쇼핑서선보여,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1061499
766,2018-10-22,부광약품파킨슨병이상운동증치료제JM010유럽임상2상승인,http://www.econovill.com/news/articleView.html?idxno=348808
767,2018-10-22,부광약품JM010유럽임상2상승인,http://kormedi.com/?p=1252632
768,2018-10-22,부광약품파킨슨병이상운동증치료제유럽임상2상승인,http://biz.chosun.com/site/data/html_dir/2018/10/22/2018102201283.html
769,2018-10-22,부광약품파킨슨JM010유럽임상2상승인,http://medipana.com/news/news_viewer.asp?NewsNum=227012&MainKind=A&NewsKind=5&vCount=12&vKind=1
770,2018-10-22,부광약품프랑스서이상운동증신약JM010임상2상계획승인받아,http://news.mk.co.kr/newsRead.php?year=2018&no=657599
771,2018-10-22,부광약품파킨슨병이상운동증치료제유럽임상2상승인,http://news.hankyung.com/article/201810220843f
772,2018-10-22,부광약품파킨슨병운동장애신약유럽임상2상승인,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181022092900017&did=1195m
773,2018-10-22,부광약품JM010유럽임상2상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2018102214031250305
774,2018-10-22,부광약품파킨슨병치료신약JM010유럽임상2상승인,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018102214062466603
775,2018-10-22,부광약품유럽서JM0102상승인내년초환자등록,http://www.medisobizanews.com/news/articleView.html?idxno=55871
776,2018-10-22,부광약품이상운동증치료제JM010유럽임상2상승인,http://www.etoday.co.kr/news/section/newsview.php?idxno=1676936
777,2018-10-22,부광약품JM010유럽임상2상승인,http://www.getnews.co.kr/news/articleView.html?idxno=101513
778,2018-10-22,부광약품이상운동증치료제JM010유럽임상2상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=223304
779,2018-10-22,부광약품파킨슨병약유럽임상2상시작,http://www.whosaeng.com/sub_read.html?uid=105352§ion=sc5
780,2018-10-22,부광약품파킨슨병이상운동증치료제유럽임상2상승인,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810220358&t=NN
781,2018-10-22,부광약품파킨슨병운동장애신약JM010유럽임상2상승인,http://view.asiae.co.kr/news/view.htm?idxno=2018102215100459422
782,2018-10-22,부광약품LID치료제프랑스2상승인,http://www.biospectator.com/view/news_view.php?varAtcId=6413
783,2018-10-22,부광약품파킨슨병운동장애신약프랑스서임상2상승인”,http://www.sedaily.com/NewsView/1S60GU0W87
784,2018-10-22,부광약품신약후보물질JM010유럽서임상2상돌입,http://www.rapportian.com/news/articleView.html?idxno=113584
785,2018-10-22,곳간채운부광약품신약RD박차,http://www.etoday.co.kr/news/section/newsview.php?idxno=1677048
786,2018-10-22,부광약품JM010유럽임상2상승인,http://www.dailymedi.com/detail.php?number=835990&thread=22r05
787,2018-10-22,부광약품LID치료신약유럽임상2상승인,http://www.monews.co.kr/news/articleView.html?idxno=120516
788,2018-10-22,부광약품잇몸병치약네오메드치약NS홈쇼핑서판매,http://www.finomy.com/news/articleView.html?idxno=59329
789,2018-10-22,부광약품2개월간377억규모안트로젠주식처분,http://www.mdtoday.co.kr/mdtoday/index.html?no=336242
790,2018-10-22,부광약품신약후보물질JM010프랑스2상임상시험계획승인,http://www.fnnews.com/news/201810221649442397
791,2018-10-22,부광약품파킨슨병이상운동증치료제유럽임상2상승인,http://biz.newdaily.co.kr/site/data/html/2018/10/22/2018102200173.html
792,2018-10-22,부광약품파킨슨병운동장애신약프랑스임상2상승인,http://www.sporbiz.co.kr/news/articleView.html?idxno=281598
793,2018-10-22,부광약품프랑스서JM010임상2상돌입,http://www.finomy.com/news/articleView.html?idxno=59333
794,2018-10-22,부광약품주가24750원장마쳐,http://www.anewsa.com/detail.php?number=1400681&thread=10r04
795,2018-10-22,부광약품JM010유럽임상2상승인,http://www.dt.co.kr/contents.html?article_no=2018102202109931102010&ref=naver
796,2018-10-22,부광약품파킨슨병운동장애치료제유럽2상승인,http://www.edaily.co.kr/news/newspath.asp?newsid=04716646619375544
797,2018-10-22,부광약품파킨슨병환자운동장애신약유럽임상2상승인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3665630
798,2018-10-23,부광약품파킨슨병신약JM010유럽임상2상승인,http://www.bosa.co.kr/news/articleView.html?idxno=2092430
799,2018-10-23,부광약품파킨슨병운동장애신약JM010유럽서2상임상시험승인받아,http://www.nextdaily.co.kr/news/article.html?id=20181022800072
800,2018-10-23,23일부광약품주가24300원,http://www.anewsa.com/detail.php?number=1401017&thread=10r04
801,2018-10-23,부광약품파킨슨병이상운동증치료제유럽임상2상승인,http://sports.khan.co.kr/news/sk_index.html?art_id=201810231454003&sec_id=561801&pt=nv
802,2018-10-23,부광약품전일대비약4하락한23750원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810230507&t=NN
803,2018-10-23,부광약품JM010유럽임상2상승인,http://www.kpanews.co.kr/article/show.asp?idx=198089&table=article&category=D
804,2018-10-23,부광약품주가23900원으로마감,http://www.anewsa.com/detail.php?number=1401752&thread=10r04
805,2018-10-24,24일부광약품주가23750원,http://www.anewsa.com/detail.php?number=1402124&thread=10r04
806,2018-10-24,부광약품신약후보물질JM010유럽임상2상계획승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=336420
807,2018-10-24,부광약품주가23850원마감해,http://www.anewsa.com/detail.php?number=1402939&thread=10r04
808,2018-10-25,부광약품전일대비약5하락한22750원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810250315&t=NN
809,2018-10-25,25일부광약품주가22750원,http://www.anewsa.com/detail.php?number=1403291&thread=10r04
810,2018-10-26,부광약품변비치료제아락실화이버출시,http://www.whosaeng.com/sub_read.html?uid=105499§ion=sc5
811,2018-10-26,부광약품변비치료제아락실화이버출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=223458
812,2018-10-26,부광약품변비치료제아락실화이버출시,http://www.getnews.co.kr/news/articleView.html?idxno=102241
813,2018-10-26,부광약품변비치료제아락실화이버출시,http://www.dailypharm.com/News/245263
814,2018-10-26,부광약품변비치료제아락실화이버출시,http://www.rapportian.com/news/articleView.html?idxno=113679
815,2018-10-26,부광약품변비치료제아락실화이버출시,http://www.bosa.co.kr/news/articleView.html?idxno=2092746
816,2018-10-26,26일부광약품주가22400원,http://www.anewsa.com/detail.php?number=1404356&thread=10r04
817,2018-10-26,부광약품부드러운변비치료제아락실화이버출시,http://www.medisobizanews.com/news/articleView.html?idxno=55962
818,2018-10-26,부광약품식이섬유함유아락실화이버출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1061721
819,2018-10-26,부광약품변비치료제아락실화이버출시,http://medipana.com/news/news_viewer.asp?NewsNum=227349&MainKind=A&NewsKind=5&vCount=12&vKind=1
820,2018-10-26,부광약품주가22150원으로마감,http://www.anewsa.com/detail.php?number=1405090&thread=10r04
821,2018-10-28,부광약품변비치료제아락실화이버출시,http://www.dailymedi.com/detail.php?number=836233&thread=22r05
822,2018-10-29,유부광약품장중신저가기록21600→21550▼50,http://www.sedaily.com/NewsView/1S63OISM5E
823,2018-10-29,부광약품주가22150원으로장마감,http://www.anewsa.com/detail.php?number=1406740&thread=10r04
824,2018-10-30,부광약품올해3Q연결영업익295억전년비6962↑,http://www.newspim.com/news/view/20181030000262
825,2018-10-30,컨센미달부광약품올해3Q연결영업익295억컨센비223↓,http://www.itooza.com/common/iview.php?no=2018103010191413257
826,2018-10-30,부광약품3Q연결영업익295억전년대비696↑,http://view.asiae.co.kr/news/view.htm?idxno=2018103010214514880
827,2018-10-30,실적속보부광약품연결20183Q영업이익295억원전년비6962,http://www.fntimes.com/html/view.php?ud=2018103010195853875dfa8b3352_18
828,2018-10-30,부광약품올해3Q영업익295억원전년比6962↑,http://news.mt.co.kr/mtview.php?no=2018103010215472636
829,2018-10-30,부광약품3분기영업이익295억원전년대비696증가,http://www.sedaily.com/NewsView/1S643KL7IP
830,2018-10-30,ET투자뉴스부광약품18년3분기실적발표영업이익2951억원전년동기대비6962증,http://www.etnews.com/20181030000102
831,2018-10-30,부광약품2018년3분기영업익295억원전년比6962증가,http://biz.chosun.com/site/data/html_dir/2018/10/30/2018103000997.html
832,2018-10-30,부광약품3분기영업익295억원6962증가,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181030060600008&did=1195m
833,2018-10-30,부광약품3Q영업익295억전년비696↑,http://www.dailypharm.com/News/245434
834,2018-10-30,부광약품3분기영업익295억원6962증가,http://www.edaily.co.kr/news/newspath.asp?newsid=02519046619378168
835,2018-10-30,부광약품3분기순이익1439억전년동기대비4379증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=223584
836,2018-10-30,공시부광약품3분기영업이익295억원전년比6962↑,http://www.newsway.co.kr/news/view?tp=1&ud=2018103010413306157
837,2018-10-30,부광약품3분기영업이익295억전년比6962↑,http://www.newsworks.co.kr/news/articleView.html?idxno=306573
838,2018-10-30,부광약품3분기영업익295억전년비6962↑,http://news.heraldcorp.com/view.php?ud=20181030000322
839,2018-10-30,부광약품3분기영업익295억전년대비696↑,http://news.hankyung.com/article/2018103093936
840,2018-10-30,30일부광약품주가21950원,http://www.anewsa.com/detail.php?number=1407106&thread=10r04
841,2018-10-30,부광약품3분기영업이익295억전년동기比약8배↑,http://www.nspna.com/news/?mode=view&newsid=314751
842,2018-10-30,부광약품3분기순이익43배↑투자잭팟,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810300298&t=NN
843,2018-10-30,부광약품3분기영업익295억원전년比6962↑,http://www.newsis.com/view/?id=NISX20181030_0000457888&cID=10401&pID=10400
844,2018-10-30,부광약품3분기영업익295억원전년比6962증가,http://daily.hankooki.com/lpage/ittech/201810/dh20181030140432145630.htm
845,2018-10-30,부광약품3Q영업익295억900만전년대비696증가,http://www.mdtoday.co.kr/mdtoday/index.html?no=337161
846,2018-10-30,부광약품3분기순이익4천급증의비밀은,http://www.sporbiz.co.kr/news/articleView.html?idxno=283950
847,2018-10-30,부광약품3분기영업익295억원전년대비6962증가,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018103011052337823
848,2018-10-30,부광약품3분기영업익대박친비결봤더니,http://www.newsway.co.kr/news/view?tp=1&ud=2018103011425506354
849,2018-10-30,부광약품3분기영업익295억전년比6962증가순이익43배↑,http://biz.newdaily.co.kr/site/data/html/2018/10/30/2018103000174.html
850,2018-10-30,부광약품3분기영업이익295억원전년동기대비6962증가,http://www.econonews.co.kr/news/articleView.html?idxno=40644
851,2018-10-30,실적발표국도화학영진약품부광약품유한양행,http://www.businesspost.co.kr/BP?command=article_view&num=100653
852,2018-10-30,부광약품영업익696증가깜짝실적,http://news.hankyung.com/article/2018103018331
853,2018-10-30,부광약품주가22250원장마쳐,http://www.anewsa.com/detail.php?number=1408033&thread=10r04
854,2018-10-31,더벨부광약품오너일가에400억원안겨준안트로젠,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201810300100048210002957
855,2018-10-31,부광약품투자사美에이서테라퓨틱스에드시보신약허가신청제출,http://www.getnews.co.kr/view.php?ud=20181031104326862641d0c69529_16
856,2018-10-31,부광약품투자사테라퓨틱스에드시보신약허가신청,http://medipana.com/news/news_viewer.asp?NewsNum=227593&MainKind=A&NewsKind=5&vCount=12&vKind=1
857,2018-10-31,부광약품투자사미에이서테라퓨틱스에드시보신약허가신청,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=223640
858,2018-10-31,부광약품투자에이서에드시보美신약허가신청,http://www.monews.co.kr/news/articleView.html?idxno=121029
859,2018-10-31,부광약품투자사美에이서에드시보신약허가신청,http://kormedi.com/?p=1253620
860,2018-10-31,부광약품美에이서테라퓨틱스에드시보신약허가신청,http://view.asiae.co.kr/news/view.htm?idxno=2018103111013855943
861,2018-10-31,부광약품투자사美FDA에에드시보품목허가신청,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810310255&t=NN
862,2018-10-31,31일부광약품주가22200원,http://www.anewsa.com/detail.php?number=1408324&thread=10r04
863,2018-10-31,부광약품투자사美에이서테라퓨틱스FDA에신약허가신청제출,http://www.etoday.co.kr/news/section/newsview.php?idxno=1681452
864,2018-10-31,부광약품투자사에이서테라퓨틱스미FDA에신약허가신청,http://news.heraldcorp.com/view.php?ud=20181031000515
865,2018-10-31,부광약품투자한美제약사FDA혈액단로스증후군치료제허가신청,http://news.mk.co.kr/newsRead.php?year=2018&no=680071
866,2018-10-31,부광약품투자사美에이서에드시보신약허가신청,http://www.newsway.co.kr/news/view?tp=1&ud=2018103111352065254
867,2018-10-31,부광약품투자사美에이서희귀질환신약허가신청제출,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1061907
868,2018-10-31,부광약품투자美제약사혈액단로스증후군신약FDA허가신청,http://www.newspim.com/news/view/20181031000475
869,2018-10-31,부광약품투자사미국에이서테라퓨틱스에드시보신약허가신청제출,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018103113534043633
870,2018-10-31,부광약품투자사美제약사신약허가신청,http://biz.newdaily.co.kr/site/data/html/2018/10/31/2018103100118.html
871,2018-10-31,부광약품투자사미에이서테라퓨틱스에드시보신약허가신청제출,http://www.mdtoday.co.kr/mdtoday/index.html?no=337353
872,2018-10-31,부광약품투자사혈관엘러스단로스증후군신약허가신청,http://news.hankyung.com/article/2018103156286
873,2018-10-31,부광약품美투자사에이서테라퓨틱스美FDA에신약허가신청,http://www.medisobizanews.com/news/articleView.html?idxno=56059
874,2018-10-31,부광약품주가22300원마감,http://www.anewsa.com/detail.php?number=1409162&thread=10r04
875,2018-10-31,부광약품美에이서에드시보신약허가신청제출,http://www.dailymedi.com/detail.php?number=836396&thread=22r05
876,2018-11-01,부광약품이출자한美바이오회사4분기연속적자투자의견매도로하향,http://www.nspna.com/news/?mode=view&newsid=315393
877,2018-11-01,1일부광약품주가22650원,http://www.anewsa.com/detail.php?number=1409595&thread=10r04
878,2018-11-01,부광약품캐나다에시린이기능성치약시린메드출시,http://www.sedaily.com/NewsView/1S70Q88X2L
879,2018-11-01,부광약품시린메드로캐나다시장진출,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018110113291768304
880,2018-11-01,부광약품시린이기능성치약시린메드캐나다시장진출,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=223713
881,2018-11-01,부광약품기능성치약시린메드캐나다시장진출,http://biz.chosun.com/site/data/html_dir/2018/11/01/2018110101614.html
882,2018-11-01,부광약품기능성치약시린메드캐나다진출,http://www.newspim.com/news/view/20181101000456
883,2018-11-01,부광약품시린이기능성치약캐나다시장진출,http://www.dailypharm.com/News/245556
884,2018-11-01,부광약품캐나다서기능성치약시린메드본격판매,http://view.asiae.co.kr/news/view.htm?idxno=2018110113560222891
885,2018-11-01,부광약품시린메드캐나다시장진출,http://www.medical-tribune.co.kr/news/articleView.html?idxno=82163
886,2018-11-01,부광약품기능성치약시린메드캐나다진출,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181101108000017&did=1195m
887,2018-11-01,부광약품시린메드캐나다서10월부터판매중,http://www.medisobizanews.com/news/articleView.html?idxno=56078
888,2018-11-01,부광약품시린메드캐나다시장진출,http://www.getnews.co.kr/view.php?ud=20181101142926789141d0c69529_16
889,2018-11-01,부광약품시린메드캐나다시장진출,http://kormedi.com/?p=1253836
890,2018-11-01,부광약품시린이기능성치약시린메드캐나다시장진출,http://www.lawissue.co.kr/view.php?ud=201811011425062849d7f4c63cc6_12
891,2018-11-01,부광약품시린이기능성치약캐나다시장진출,http://www.sisajournal-e.com/biz/article/190950
892,2018-11-01,부광약품시린메드캐나다시장진출,http://www.newsway.co.kr/news/view?tp=1&ud=2018110114511374851
893,2018-11-01,부광약품시린메드캐나다진출소비자전문가에게검증받아,http://news.mk.co.kr/newsRead.php?year=2018&no=684010
894,2018-11-01,부광약품시린메드1000억원규모캐나다시린이치약시장진출,http://www.etoday.co.kr/news/section/newsview.php?idxno=1682313
895,2018-11-01,부광약품기능성치약시린메드캐나다시장진출,http://www.rapportian.com/news/articleView.html?idxno=113823
896,2018-11-01,부광약품기능성치약시린메드캐나다시장진출,http://daily.hankooki.com/lpage/ittech/201811/dh20181101180156145630.htm
897,2018-11-02,부광약품시린메드캐나다시장진출,http://www.kpanews.co.kr/article/show.asp?idx=198421&table=article&category=D
898,2018-11-02,부광약품기능성치약시린메드캐나다시장진출,http://www.businesskorea.co.kr/news/articleView.html?idxno=26232
899,2018-11-02,한경로보뉴스부광약품5이상상승외국계증권사창구의거래비중15수준,http://news.hankyung.com/article/201811023931L
900,2018-11-02,3분기매출성장은한미대웅종근당영업이익은부광약품눈길,http://www.sisajournal-e.com/biz/article/191001
901,2018-11-02,부광약품바이오유럽미팅진행및신약JM010유럽임상직접점검,http://www.getnews.co.kr/view.php?ud=20181102150745970141d0c69529_16
902,2018-11-02,부광약품바이오유럽참가비즈니스미팅진행,http://medipana.com/news/news_viewer.asp?NewsNum=227776&MainKind=A&NewsKind=5&vCount=12&vKind=1
903,2018-11-02,부광약품유희원대표바이오유럽참석신약JM010유럽임상점검”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1682745
904,2018-11-02,부광약품덴마크바이오유럽참가,http://news.hankyung.com/article/201811024947f
905,2018-11-02,부광약품유럽서파킨슨병약부작용치료신약기술수출타진,http://news.mk.co.kr/newsRead.php?year=2018&no=687251
906,2018-11-02,부광약품바이오유럽참석파킨슨병치료제기술수출타진,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811020666&t=NN
907,2018-11-02,부광약품바이오유럽참석파킨슨병치료제기술수출타진,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018110216342115844
908,2018-11-02,부광약품덴마크바이오유럽컨퍼런스참석,http://view.asiae.co.kr/news/view.htm?idxno=2018110218212570138
909,2018-11-02,부광약품주가23650원으로장마감,http://www.anewsa.com/detail.php?number=1411259&thread=10r04
910,2018-11-03,부광약품유희원대표바이오유럽JM010임상현장지휘,http://www.edaily.co.kr/news/newspath.asp?newsid=01305446619402112
911,2018-11-03,부광약품기능성치약시린메드캐나다시장진출,http://www.mdtoday.co.kr/mdtoday/index.html?no=337661
912,2018-11-03,부광약품유럽서JM010홍보전나서,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1062014
913,2018-11-04,부광약품바이오유럽에서신약JM010유럽임상직접점검,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=223786
914,2018-11-05,제약선진국을공략하라②부광약품유럽북미시장노크,http://news.heraldcorp.com/view.php?ud=20181105000160
915,2018-11-05,5일부광약품주가23400원,http://www.anewsa.com/detail.php?number=1411965&thread=10r04
916,2018-11-05,부광약품바이오유럽서미팅신약JM010유럽임상점검,http://www.kpanews.co.kr/article/show.asp?idx=198518&table=article&category=D
917,2018-11-05,부광약품주가23850원으로장마감,http://www.anewsa.com/detail.php?number=1412808&thread=10r04
918,2018-11-06,영진약품악화현대약품하락부광약품대박,http://www.dailymedi.com/detail.php?number=836566&thread=22r05
919,2018-11-06,6일부광약품주가24250원,http://www.anewsa.com/detail.php?number=1413117&thread=10r04
920,2018-11-06,부광약품전일대비약3상승한24600원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811060319&t=NN
921,2018-11-06,부광약품주가24850원으로장마감,http://www.anewsa.com/detail.php?number=1413830&thread=10r04
922,2018-11-07,7일부광약품주가25200원,http://www.anewsa.com/detail.php?number=1414186&thread=10r04
923,2018-11-07,부광약품주가24500원으로종료,http://www.anewsa.com/detail.php?number=1414981&thread=10r04
924,2018-11-08,8일부광약품주가24950원,http://www.anewsa.com/detail.php?number=1415347&thread=10r04
925,2018-11-08,부광약품드라마촬영현장에건기식증정,http://www.dailypharm.com/News/245921
926,2018-11-08,부광약품촬영장간식∙선물에아락실광고모델길용우미소화답,http://www.getnews.co.kr/view.php?ud=20181108143208987941d0c69529_16
927,2018-11-08,부광약품주가24900원으로종료,http://www.anewsa.com/detail.php?number=1416105&thread=10r04
928,2018-11-09,9일부광약품주가24550원,http://www.anewsa.com/detail.php?number=1416462&thread=10r04
929,2018-11-09,11월9일부광약품주식종목24550원141,http://www.nbntv.co.kr/news/articleView.html?idxno=127627
930,2018-11-09,부광약품주가24850원으로마감,http://www.anewsa.com/detail.php?number=1417037&thread=10r04
931,2018-11-12,부광약품3분기연결영업이익295억전년비696↑,http://www.newspim.com/news/view/20181112000760
932,2018-11-12,실적속보부광약품3Q영업이익295억전년비696↑,http://www.itooza.com/common/iview.php?no=2018111216424116342
933,2018-11-12,부광약품주가24400원으로마감,http://www.anewsa.com/detail.php?number=1418393&thread=10r04
934,2018-11-13,부광약품주가25250원장마쳐,http://www.anewsa.com/detail.php?number=1419380&thread=10r04
935,2018-11-14,더벨부광약품안트로젠지분처분으로3Q순이익44배↑,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201811130100020490001266
936,2018-11-14,14일부광약품주가25150원,http://www.anewsa.com/detail.php?number=1419764&thread=10r04
937,2018-11-15,15일부광약품주가25350원,http://www.anewsa.com/detail.php?number=1420868&thread=10r04
938,2018-11-15,부광약품주가25700원마감해,http://www.anewsa.com/detail.php?number=1421603&thread=10r04
939,2018-11-16,16일부광약품주가26150원,http://www.anewsa.com/detail.php?number=1421909&thread=10r04
940,2018-11-16,부광약품주가26200원으로장마감,http://www.anewsa.com/detail.php?number=1422522&thread=10r04
941,2018-11-19,19일부광약품주가26750원,http://www.anewsa.com/detail.php?number=1423317&thread=10r04
942,2018-11-19,부광약품5거래일연속상승전일대비2상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811190348&t=NN
943,2018-11-19,재계34세시즌2부광약품막내리는공동경영,http://news.bizwatch.co.kr/article/policy/2018/11/15/0038/naver
944,2018-11-19,부광약품주가26900원으로장마감,http://www.anewsa.com/detail.php?number=1424231&thread=10r04
945,2018-11-20,20일부광약품주가26900원,http://www.anewsa.com/detail.php?number=1424545&thread=10r04
946,2018-11-21,21일부광약품주가26550원,http://www.anewsa.com/detail.php?number=1425576&thread=10r04
947,2018-11-21,부광약품11월25일일까지건강기능식품품질관리사원모집,http://www.ekn.kr/news/article.html?no=398964
948,2018-11-21,부광약품주가27000원마감,http://www.anewsa.com/detail.php?number=1426285&thread=10r04
949,2018-11-22,22일부광약품주가26800원,http://www.anewsa.com/detail.php?number=1426660&thread=10r04
950,2018-11-23,부광약품주가26350원으로장마감,http://www.anewsa.com/detail.php?number=1428367&thread=10r04
951,2018-11-26,26일부광약품주가26950원,http://www.anewsa.com/detail.php?number=1429035&thread=10r04
952,2018-11-26,부광약품주가26900원마감해,http://www.anewsa.com/detail.php?number=1429741&thread=10r04
953,2018-11-27,27일부광약품주가26750원,http://www.anewsa.com/detail.php?number=1430082&thread=10r04
954,2018-11-27,부광약품㈜해외임상부문경력사원모집12월2일채용마감,http://www.ekn.kr/news/article.html?no=400103
955,2018-11-27,부광약품주가26800원마감해,http://www.anewsa.com/detail.php?number=1430792&thread=10r04
956,2018-11-28,마이다스의손부광약품투자대박행진비결은,http://news.mt.co.kr/mtview.php?no=2018112715425736132
957,2018-11-28,부광약품주가26700원으로종료,http://www.anewsa.com/detail.php?number=1431860&thread=10r04
958,2018-11-29,29일부광약품주가26950원,http://www.anewsa.com/detail.php?number=1432244&thread=10r04
959,2018-11-29,부광약품당뇨병신약2상후기임상마무리개발시연간3조원매출예상,http://www.g-enews.com/ko-kr/news/article/news_all/20181129114454475225b4ac5ede_1/article.html
960,2018-11-29,부광약품당뇨병신약후기2상투약완료,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1063027
961,2018-11-29,부광약품당뇨병치료제MLR1023임상2상환자투약완료,http://biz.chosun.com/site/data/html_dir/2018/11/29/2018112901818.html
962,2018-11-29,부광약품당뇨병신약MLR1023후기2상임상투약완료,http://www.kpanews.co.kr/article/show.asp?idx=199428&table=article&category=D
963,2018-11-29,부광약품당뇨병신약MLR1023후기2상임상투약완료,http://www.newsway.co.kr/news/view?tp=1&ud=2018112913340251194
964,2018-11-29,부광약품당뇨병신약MLR1023후기2상임상투약완료,http://www.etoday.co.kr/news/section/newsview.php?idxno=1693436
965,2018-11-29,부광약품당뇨병신약MLR1023후기2상임상투약완료,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1122931&REFERER=NP
966,2018-11-29,부광약품당뇨병신약임상참가자투약완료,http://www.edaily.co.kr/news/newspath.asp?newsid=02938886619410640
967,2018-11-29,부광약품당뇨병신약후기임상시험환자투약완료,http://www.fnnews.com/news/201811291347392568
968,2018-11-29,부광약품당뇨병치료신약물질연내2상종료,http://www.dailypharm.com/Users/News/NewsView.html?ID=246847&REFERER=NP
969,2018-11-29,부광약품당뇨신약후기2상투약완료신약개발가능성↑,http://www.medisobizanews.com/news/articleView.html?idxno=56576
970,2018-11-29,부광약품당뇨신약MLR10232상후기임상약물투여완료,http://news.mk.co.kr/newsRead.php?year=2018&no=747446
971,2018-11-29,부광약품당뇨병신약후기2상임상투약완료,http://medipana.com/news/news_viewer.asp?NewsNum=229377&MainKind=A&NewsKind=5&vCount=12&vKind=1
972,2018-11-29,부광약품당뇨병신약MLR1023임상2b상투약완료,http://news.hankyung.com/article/2018112970646
973,2018-11-29,부광약품당뇨병신약임상2상환자투약완료,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811290490&t=NN
974,2018-11-29,부광약품당뇨병신약MLR1023후기2상임상투약완료,http://www.asiatime.co.kr/news/articleView.html?idxno=214403
975,2018-11-29,부광약품당뇨신약후기2상임상투약완료,http://www.dailymedi.com/detail.php?number=837553&thread=22r05
976,2018-11-29,부광약품당뇨병신약MLR1023후기2상임상투약완료,http://biz.newdaily.co.kr/site/data/html/2018/11/29/2018112900174.html
977,2018-11-29,부광약품당뇨병신약MLR1023후기2상임상투약완료,http://www.getnews.co.kr/view.php?ud=20181129164716581141d0c69529_16
978,2018-11-29,부광약품당뇨신약MLR1023후기2상임상투약완료,http://kormedi.com/?p=1257118
979,2018-11-29,부광약품당뇨병신약MLR1023후기2상임상투약완료,http://www.sedaily.com/NewsView/1S7DM8AT5N
980,2018-11-29,부광약품12월2일일까지해외임상부문경력사원모집,http://www.ekn.kr/news/article.html?no=400669
981,2018-11-29,부광약품주가26850원으로장마감,http://www.anewsa.com/detail.php?number=1432974&thread=10r04
982,2018-11-30,부광약품당뇨병신약MLR1023후기2상투약완료,http://www.bosa.co.kr/news/articleView.html?idxno=2095181
983,2018-11-30,부광약품당뇨병신약임상2상환자투약완료,http://www.sporbiz.co.kr/news/articleView.html?idxno=293101
984,2018-11-30,30일부광약품주가26950원,http://www.anewsa.com/detail.php?number=1433302&thread=10r04
985,2018-11-30,금일증시부광약품주가30일현재26900원,http://www.nbntv.co.kr/news/articleView.html?idxno=136268
986,2018-11-30,부광약품주가26950원으로마감,http://www.anewsa.com/detail.php?number=1433930&thread=10r04
987,2018-12-02,부광약품당뇨병신약후보물질임상2상환자투약완료,http://www.mdtoday.co.kr/mdtoday/index.html?no=340258
988,2018-12-03,3일부광약품주가27050원,http://www.anewsa.com/detail.php?number=1434713&thread=10r04
989,2018-12-03,부광약품남동구소외계층지원시린메드치약3만개기탁,http://www.joongdo.co.kr/main/view.php?key=20181203010000799
990,2018-12-03,부광약품시린메드치약3만개인천남동구에기탁,http://www.nbnnews.co.kr/news/articleView.html?idxno=206279
991,2018-12-03,인천부광약품소외계층나눔손길치약3만개기탁,http://www.newscj.com/news/articleView.html?idxno=579081
992,2018-12-03,부광약품인천남동구소외계층에치약3만개지원,http://www.fnnews.com/news/201812031613302408
993,2018-12-03,부광약품주식회사남동구소외계층지원시린메드치약3만개기탁,http://www.upkorea.net/news/articleView.html?idxno=443690
994,2018-12-03,부광약품주식회사치약3만개남동구기탁,http://www.incheonilbo.com/news/articleView.html?idxno=916130
995,2018-12-04,부광약품주식회사남동구소외계층지원시린메드치약3만개기탁,http://www.wikitree.co.kr/main/news_view.php?id=386904
996,2018-12-04,더벨부광약품美바이오벤처에9억투자또대박낼까,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201811300100053970003308
997,2018-12-05,5일부광약품주가26950원,http://www.anewsa.com/detail.php?number=1436527&thread=10r04
998,2018-12-05,부광약품주가27050원마감,http://www.anewsa.com/detail.php?number=1437307&thread=10r04
999,2018-12-07,부광약품주당200원현금배당결정,http://www.newspim.com/news/view/20181207000150
1000,2018-12-07,부광약품주당200원현금배당,http://yna.kr/AKR20181207047600008?did=1195m
1001,2018-12-07,부광약품주당200원배당결정,http://view.asiae.co.kr/news/view.htm?idxno=2018120709553977138
1002,2018-12-07,부광약품주당200원현금배당결정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1696816
1003,2018-12-07,부광약품1주당200원결산배당,http://www.sedaily.com/NewsView/1S8DFNQ6EC
1004,2018-12-07,부광약품주당200원현금배당결정,http://news.heraldcorp.com/view.php?ud=20181207000157
1005,2018-12-07,부광약품주당200원현금배당결정,http://www.newsis.com/view/?id=NISX20181207_0000495635&cID=10401&pID=10400
1006,2018-12-07,공시부광약품보통주1주당200원현금결산배당결정,http://www.newsway.co.kr/news/view?tp=1&ud=2018120709552002640
1007,2018-12-07,공시부광약품1주당03주주식배당결정,http://www.newsway.co.kr/news/view?tp=1&ud=2018120709595305855
1008,2018-12-07,공시거래소부광약품매매거래30분간정지,http://www.newsway.co.kr/news/view?tp=1&ud=2018120709581585279
1009,2018-12-07,부광약품주당03주배당결정,http://view.asiae.co.kr/news/view.htm?idxno=2018120710011332350
1010,2018-12-07,부광약품주당03주배당결정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1696821
1011,2018-12-07,부광약품주당03주주식배당결정,http://www.newsis.com/view/?id=NISX20181207_0000495656&cID=10401&pID=10400
1012,2018-12-07,부광약품주당03주주식배당결정,http://news.heraldcorp.com/view.php?ud=20181207000175
1013,2018-12-07,부광약품30분간매매거래정지,http://www.asiatoday.co.kr/view.php?key=20181207010004269
1014,2018-12-07,부광약품주당200원현금배당결정,http://news.mt.co.kr/mtview.php?no=2018120710170655020
1015,2018-12-07,부광약품주당200원현금배당결정,http://www.asiatoday.co.kr/view.php?key=20181207010004284
1016,2018-12-07,부광약품주당200원현금배당결정,http://www.edaily.co.kr/news/newspath.asp?newsid=02027046619436224
1017,2018-12-07,부광약품주당200원현금배당결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=340888
1018,2018-12-07,7일부광약품주가27200원,http://www.anewsa.com/detail.php?number=1438766&thread=10r04
1019,2018-12-07,부광약품보통주당200원현금배당‥03주주식배당,http://medipana.com/news/news_viewer.asp?NewsNum=230833&MainKind=A&NewsKind=5&vCount=12&vKind=1
1020,2018-12-07,부광약품주당200원현금배당결정,http://www.newsprime.co.kr/news/article.html?no=439117
1021,2018-12-07,부광약품거래량증가하며주가상승주가378↑,http://www.tfnews.co.kr/news/article.html?no=57440
1022,2018-12-07,유희원부광약품대표효율적투자로성장지속할것,http://news.mk.co.kr/newsRead.php?year=2018&no=766326
1023,2018-12-10,전일주요공시대우조선해양부광약품삼성중공업외,http://www.etoday.co.kr/news/section/newsview.php?idxno=1697358
1024,2018-12-10,더벨부광약품역대최대30주식배당나선까닭은,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201812070100011630000710
1025,2018-12-10,10일부광약품주가27250원,http://www.anewsa.com/detail.php?number=1440010&thread=10r04
1026,2018-12-12,12일부광약품주가26900원,http://www.anewsa.com/detail.php?number=1442044&thread=10r04
1027,2018-12-12,장마감보고서12일부광약품주가26900원장마쳐,http://www.anewsa.com/detail.php?number=1442718&thread=10r04
1028,2018-12-13,13일부광약품주가27550원,http://www.anewsa.com/detail.php?number=1443078&thread=10r04
1029,2018-12-14,14일부광약품주가27700원,http://www.anewsa.com/detail.php?number=1444306&thread=10r04
1030,2018-12-17,부광약품당뇨병신약美서후기2상임상완료,http://www.g-enews.com/ko-kr/news/article/news_all/20181217092844548425b4ac5ede_1/article.html
1031,2018-12-17,부광약품당뇨병신약MLR1023후기2상임상종료,http://www.getnews.co.kr/view.php?ud=20181217093442908841d0c69529_16
1032,2018-12-17,부광약품당뇨병신약MLR1023후기2상임상종료,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=225516
1033,2018-12-17,부광약품당뇨병신약MLR1023후기2상임상완료내달주요결과발표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1700366
1034,2018-12-17,부광약품당뇨신약MLR1023후기2상임상종료,http://www.newsway.co.kr/news/view?tp=1&ud=2018121709504281343
1035,2018-12-17,부광약품당뇨병신약MLR1023후기2상임상종료,http://biz.newdaily.co.kr/site/data/html/2018/12/17/2018121700032.html
1036,2018-12-17,부광약품당뇨신약MLR1023후기임상2상종료,http://www.econovill.com/news/articleView.html?idxno=352812
1037,2018-12-17,부광약품당뇨신약MLR1023후기2상종료,http://kormedi.com/?p=1258866
1038,2018-12-17,부광약품당뇨병신약MLR1023후기2상임상종료,http://medipana.com/news/news_viewer.asp?NewsNum=231270&MainKind=A&NewsKind=5&vCount=12&vKind=1
1039,2018-12-17,부광약품당뇨병신약후기임상2상종료,http://view.asiae.co.kr/news/view.htm?idxno=2018121710030348092
1040,2018-12-17,부광약품당뇨병신약MLR1023임상2b상종료,http://www.edaily.co.kr/news/newspath.asp?newsid=01918806619439504
1041,2018-12-17,부광약품당뇨병신약MLR1023후기2상임상종료,http://www.mdtoday.co.kr/mdtoday/index.html?no=341730
1042,2018-12-17,부광약품당뇨병신약MLR1023美서후기2상임상완료,http://www.businesskorea.co.kr/news/articleView.html?idxno=27488
1043,2018-12-17,부광약품당뇨병신약후보MLR1023후기2상종료,http://www.dailypharm.com/Users/News/NewsView.html?ID=247635&REFERER=NP
1044,2018-12-17,부광약품당뇨병신약MLR1023후기2상임상완료,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812170247&t=NN
1045,2018-12-17,부광약품당뇨병신약후기2상종료사업성1월윤곽,http://www.sedaily.com/NewsView/1S8I0JWA5I
1046,2018-12-17,부광약품의당뇨병신약후기2상1년4개월만에종료,http://www.medisobizanews.com/news/articleView.html?idxno=56885
1047,2018-12-17,부광약품당뇨병신약MLR1023후기2상임상종료,http://news.mk.co.kr/newsRead.php?year=2018&no=784677
1048,2018-12-17,부광약품당뇨병신약후기2상종료내년6월결과발표,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1063530
1049,2018-12-17,부광약품당뇨신약MLR1023임상2상후기종료,http://www.sporbiz.co.kr/news/articleView.html?idxno=297239
1050,2018-12-17,부광약품당뇨병신약MLR1023후기2상임상종료,http://www.asiatime.co.kr/news/articleView.html?idxno=218031
1051,2018-12-17,부광약품당뇨병신약MLR1023후기2상임상종료,http://www.fnnews.com/news/201812171645238029
1052,2018-12-17,부광약품당뇨병신약후기2상임상종료,http://www.dt.co.kr/contents.html?article_no=2018121702109931102008&ref=naver
1053,2018-12-17,부광약품당뇨병신약후기임상2상완료,http://www.newspim.com/news/view/20181217000621
1054,2018-12-17,장마감보고서17일부광약품주가27850원으로마감,http://www.anewsa.com/detail.php?number=1446610&thread=10r04
1055,2018-12-17,부광약품당뇨신약MLR1023후기임상2상종료,http://www.monews.co.kr/news/articleView.html?idxno=123162
1056,2018-12-18,부광약품기대주당뇨병신약내년기술수출난관넘을까,http://biz.newdaily.co.kr/site/data/html/2018/12/18/2018121800056.html
1057,2018-12-18,장마감보고서18일부광약품주가27950원으로장마감,http://www.anewsa.com/detail.php?number=1447788&thread=10r04
1058,2018-12-19,부광약품복합비염치료신약딜라스틴나잘스프레이출시,http://www.newspim.com/news/view/20181219000207
1059,2018-12-19,부광약품항히스타민스테로이드복합비염치료제신약딜라스틴출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1701432
1060,2018-12-19,부광약품알레르기비염치료제딜라스틴출시,http://www.g-enews.com/ko-kr/news/article/news_all/20181219103950688025b4ac5ede_1/article.html
1061,2018-12-19,부광약품알레르기비염복합스프레이딜라스틴출시,http://www.edaily.co.kr/news/newspath.asp?newsid=02361606619440160
1062,2018-12-19,19일부광약품주가28300원,http://www.anewsa.com/detail.php?number=1448224&thread=10r04
1063,2018-12-19,주식실시간부광약품주가19일현재28300원,http://www.nbntv.co.kr/news/articleView.html?idxno=143943
1064,2018-12-19,부광약품비염치료제딜라스틴나잘스프레이출시,http://www.newsis.com/view/?id=NISX20181219_0000507115&cID=13001&pID=13000
1065,2018-12-19,부광약품알레르기비염복합제신약딜라스틴나잘스프레이출시,http://www.newsway.co.kr/news/view?tp=1&ud=2018121915285751376
1066,2018-12-19,오늘의신상품부광약품복합비염치료제딜라스틴나잘스프레이출시,http://www.econovill.com/news/articleView.html?idxno=353018
1067,2018-12-19,제약토크부광약품알레르기비염복합스프레이딜라스틴,https://www.insight.co.kr/news/199041
1068,2018-12-20,20일부광약품주가28950원,http://www.anewsa.com/detail.php?number=1449555&thread=10r04
1069,2018-12-21,JP모건헬스케어참석기업관심셀트리온부광약품등,http://news.hankyung.com/article/2018122196226
1070,2018-12-21,21일부광약품주가29050원,http://www.anewsa.com/detail.php?number=1450823&thread=10r04
1071,2018-12-21,부광약품5거래일연속상승전일대비2상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812210427&t=NN
1072,2018-12-21,장마감보고서21일부광약품주가29500원으로종료,http://www.anewsa.com/detail.php?number=1451549&thread=10r04
1073,2018-12-24,24일부광약품주가29450원,http://www.anewsa.com/detail.php?number=1452423&thread=10r04
1074,2018-12-24,12월24일부광약품주식그래프01729450원,http://www.nbntv.co.kr/news/articleView.html?idxno=146041
1075,2018-12-24,장마감보고서24일부광약품주가29450원장마쳐,http://www.anewsa.com/detail.php?number=1453197&thread=10r04
1076,2018-12-26,12월26일부광약품오늘증권시세20428850원,http://www.nbntv.co.kr/news/articleView.html?idxno=146705
1077,2018-12-26,부광약품주가주가정보26일현재28850원및오늘시세및주식시황,http://www.cctvnews.co.kr/news/articleView.html?idxno=94191
1078,2018-12-26,26일부광약품주가28700원장마쳐,http://www.anewsa.com/detail.php?number=1454981&thread=10r04
1079,2018-12-27,한경로보뉴스부광약품5이상상승기관12일연속순매수189만주,http://news.hankyung.com/article/201812275682L
1080,2018-12-27,유부광약품전일대비724상승일일회전율은039기록,http://www.sedaily.com/NewsView/1S8MMEPO6O
1081,2018-12-27,부광약품003000종목알파고분석외국인기관실시간수급과추가매수확률은,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812270175&t=NN
1082,2018-12-27,부광약품전일대비약9상승한24000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812270223&t=NN
1083,2018-12-27,부광약품주가및증권시세및종목관련동향정보27일현재23750원,http://www.gokorea.kr/news/articleView.html?idxno=64841
1084,2018-12-27,오늘주식부광약품주가27일현재23750원,http://www.nbntv.co.kr/news/articleView.html?idxno=148400
1085,2018-12-27,부광약품주가증권시세27일현재23250원및증권차트,http://www.cctvnews.co.kr/news/articleView.html?idxno=95571
1086,2018-12-27,부광약품6대급등다시상승흐름이어지나,http://www.econonews.co.kr/news/articleView.html?idxno=47639
1087,2018-12-27,장종리포트부광약품주가24000원으로장마감,http://www.anewsa.com/detail.php?number=1456377&thread=10r04
1088,2018-12-28,부광약품주식증권28일현재23950원,http://www.nbntv.co.kr/news/articleView.html?idxno=151220
1089,2018-12-28,부광약품전일대비약4상승한24850원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812280350&t=NN
1090,2018-12-28,부광약품주가12월28일현재24850원증권시세,http://www.cctvnews.co.kr/news/articleView.html?idxno=96157
1091,2018-12-31,2018최종가격부광약품전일대비333올라주가24800원28일장마감 ,http://www.fintechpost.co.kr/news/articleView.html?idxno=13246
1092,2018-12-31,올해주식배당제약바이오기업은‥부광약품등10개사,http://medipana.com/news/news_viewer.asp?NewsNum=232835&MainKind=A&NewsKind=5&vCount=12&vKind=1
1093,2018-12-31,부광약품셀트리온등상장제약바이오社잇달아주식배당,http://www.mdtoday.co.kr/mdtoday/index.html?no=342845
1094,2018-12-31,12월31일부광약품증권투자24800원333,http://www.nbntv.co.kr/news/articleView.html?idxno=152609
1095,2018-12-31,부광약품주가12월31일현재24800원및종목차트,http://www.cctvnews.co.kr/news/articleView.html?idxno=96518
1096,2018-12-31,31일부광약품주가24800원,http://www.anewsa.com/detail.php?number=1458736&thread=10r04
1097,2018-12-31,증시실황31일부광약품주가24800원,http://www.anewsa.com/detail.php?number=1458803&thread=10r02
1098,2018-12-31,31일마감보고부광약품주가24800원으로마감,http://www.anewsa.com/detail.php?number=1459580&thread=10r04
